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I.  General Information 
 
All manipulations of air-sensitive materials were carried out in oven-dried glassware under 
an atmosphere of argon or nitrogen using standard Schlenk or glovebox techniques. Glovebox 
manipulations were carried out under an atmosphere of nitrogen. THF and CH2Cl2 were 
purified and dried using a solvent purification system that contained activated alumina under 
argon. Unless otherwise noted, all commercially available reagents were used as received, 
including NiBr2⋅diglyme (Sigma-Aldrich) and DMA (anhydrous, 99.8%, Sigma-Aldrich). 
Ligand L* (one step)1 and 3-phenyl-1-(trimethylsilyl)propan-1-one2 were prepared according 
to literature procedures. Aldehydes that are not commercially available were prepared 
according to a literature procedure.3 
1H and 13C NMR data were collected on a Bruker 400 MHz, a Varian 300 MHz, or a Varian 
500 MHz spectrometer at ambient temperature and are reported in ppm relative to residual 
CHCl3 (δ 7.26, 1H NMR; δ 77.36, 13C NMR); s = singlet, d = doublet, t = triplet, q = quartet, p = 
                                                
(1) Espelt, L. R.; McPherson, I. S.; Wiensch, E. M.; Yoon, T. P. J. Am. Chem. Soc. 2015, 137, 
2452–2455. 
(2) Decostanzi, M.; Van Der Lee, A.; Campagne, J.-M.; Leclerc, E. Adv. Synth. Catal. 2015, 357, 
3091–3097. 
(3) Hoover, J. M.; Stahl, S. S. Org. Synth. 2013, 90, 240–250. 
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pentet, sept = septuplet, m = multiplet, br = broad. IR spectra were obtained on a PerkinElmer 
Paragon 1000 spectrometer using thin films deposited on NaCl plates and are reported in 
frequency of absorption (cm-1). HR-MS were acquired by the Caltech Mass Spectrometry 
Facility using a JEOL JMS-600H MS in fast atom bombardment (FAB+) or electron ionization 
(EI+) mode, or using a Waters LCT Premier XE TOF MS in electrospray ionization (ESI+) mode. 
LC-MS were obtained on an Agilent 5975C GC/MSD System in electron ionization (EI+) mode. 
Optical rotations were measured on a Jasco P-2000 polarimeter operating on the sodium D-line 
(589 nm) using a 100 mm pathlength cell. Analytical SFC was performed on a Mettler SFC 
supercritical CO2 analytical chromatography system utilizing CHIRALPAK (AD-H, IC-3) or 
CHIRALCEL (OD-H, OJ) columns (4.6 mm x 25 cm) obtained from Daicel Chemical Industries, 
Ltd. Preparative SFC was performed on a JASCO SFC supercritical CO2 preparative 
chromatography system utilizing a CHIRALPAK AD-H column (10 mm x 250 cm) obtained 
from Daicel Chemical Industries, Ltd. GC analyses were obtained on an Agilent 6890N GC. 
Flash column chromatography was performed using silica gel (SiliaFlash® P60, particle size 40-
63 μm, Silicycle). Thin-layer chromatography (TLC) and preparatory TLC were performed 
using Merck silica gel 60 F254 pre-coated plates (0.25 mm) and visualized by UV fluorescence 
quenching and KMnO4 staining. X-ray crystallographic analysis was carried out by the Caltech 
X-Ray Crystallography Facility using a Bruker APEX-II CCD diffractometer. ESI–MS 
experiments were conducted by direct injection using a Thermo Scientific LTQ linear ion trap 
mass spectrometer. X-band EPR measurements were collected on a Bruker EMX spectrometer; 
EPR simulation was conducted using EasySpin.4 
 
  
                                                 
(4) Stoll, S.; Schweiger, A. J. Magn. Reson. 2006, 178, 42–55. 
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II.  Preparation of Electrophiles 
 
The yields have not been optimized. 
 
General Procedure A: Preparation of α-hydroxysilanes (for substrates that contain at 
least one aryl substituent on silicon). A flame-dried round-bottom flask was charged with a 
glass-covered magnetic stir bar, pellets of Li metal (2.3 equiv), and R3SiCl (if a solid), and then 
it was sealed with a rubber septum cap. Next, the flask was evacuated and backfilled with an 
argon-filled balloon (three cycles). THF (to generate a solution with [R3SiCl] = 1.0 M) was then 
added, followed by R3SiCl (if a liquid) as a steady stream. The resulting mixture was stirred at 
room temperature for 16 h (note: after ~20 min of stirring, the reaction mixture had turned 
dark green or brown). 
Next, a solution of the aldehyde (0.75 equiv) in THF ([aldehyde] = 0.38 M) was prepared in 
a flame-dried round-bottom flask under an atmosphere of nitrogen. The resulting solution was 
cooled to –78 °C, and the solution of the lithiated silane was then added dropwise over 5 min. 
Next, the reaction mixture was warmed to room temperature and stirred for 16 h. The mixture 
was quenched through the addition of a saturated solution of NH4Cl (1.0 mL/mmol of R3SiCl), 
and the resulting mixture was extracted three times with EtOAc. The combined organic layers 
were dried over MgSO4, filtered, and concentrated. The resulting α-hydroxysilane was 
purified via flash chromatography (the α-hydroxysilane can be visualized using KMnO4). 
 
 
1-(Ethyldiphenylsilyl)hexan-1-ol. The title compound was synthesized according to 
General Procedure A from n-hexanal (0.83 mL, 6.8 mmol) and chloro(ethyl)diphenylsilane5 
(2.22 g, 9.0 mmol). The product was purified by flash chromatography (2 → 5% EtOAc in 
hexanes), which provided 1.60 g (76% yield) of a colorless oil. 
1H NMR (400 MHz, CDCl3) δ 7.66–7.53 (m, 4H), 7.47–7.31 (m, 6H), 3.98 (dd, J = 9.4, 3.2 Hz, 
1H), 1.66–1.52 (m, 3H), 1.38–1.11 (m, 8H), 1.06 (t, J = 7.8 Hz, 3H), 0.87 (t, J = 6.9 Hz, 3H); 
13C NMR (101 MHz, CDCl3) δ 135.8, 135.7, 134.1, 133.9, 129.8, 129.7, 128.17, 128.16, 64.2, 33.8, 
31.8, 26.9, 22.9, 14.3, 7.8, 3.1; 
FT‐IR (thin film) 3368, 3070, 2962, 1428, 1261, 1094, 1030, 863 cm‐1; 
HR‐MS (FAB+) m/z [M+H]+–H2 calcd for C20H27OSi: 311.1831, found: 311.1835. 
 
 
  
                                                 
(5) Kwak, Y.-W.; Lee, K.-K. J. Organomet. Chem. 1997, 542, 219–225. 
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1-(Ethyldiphenylsilyl)-2-phenylethan-1-ol. The title compound was synthesized according 
to General Procedure A from 2-phenylacetaldehyde (0.80 mL, 6.8 mmol) and 
chloro(ethyl)diphenylsilane (2.22 g, 9.0 mmol). The product was purified by flash 
chromatography (0 → 6% EtOAc in hexanes), which provided 0.41 g (18% yield) of a colorless 
oil. 
1H NMR (400 MHz, CDCl3) δ 7.69 – 7.63 (m, 4H), 7.44 – 7.37 (m, 6H), 7.33 – 7.27 (m, 2H), 
7.25 – 7.18 (m, 3H), 4.16 (dd, J = 12.0, 2.7 Hz, 1H), 2.93 (dd, J = 14.0, 2.7 Hz, 1H), 2.76 (dd, J = 
14.0, 11.9 Hz, 1H), 1.53 (s, 1H), 1.27 – 1.17 (m, 2H), 1.08 (t, J = 7.6 Hz, 3H); 
13C NMR (101 MHz, CDCl3) δ 139.9, 135.94, 135.88 134.6, 134.01, 133.97, 129.93, 129.91, 129.4, 
128.9, 128.31, 128.28, 128.25, 126.8, 65.4, 40.3, 7.9, 3.2; 
FT‐IR (thin film) 3546, 3068, 2913, 1454, 1428, 1260, 1111, 1012, 856 cm‐1; 
HR‐MS (FAB+) m/z [M+H]+ calcd for C22H25OSi: 333.1675, found: 333.1646. 
 
 
 
1-(Ethyldiphenylsilyl)pent-4-en-1-ol. The title compound was synthesized according to 
General Procedure A from pent-4-enal (0.50 mL, 5.06 mmol) and chloro(ethyl)diphenylsilane 
(1.68 g, 6.8 mmol). The product was purified by flash chromatography (2 → 4% EtOAc in 
hexanes), which provided 0.42 g (27% yield) of a colorless oil. 
1H NMR (400 MHz, CDCl3) δ 7.65 – 7.54 (m, 4H), 7.47 – 7.33 (m, 6H), 5.95 – 5.73 (m, 1H), 
5.04 (dq, J = 17.1, 1.7 Hz, 1H), 4.98 (ddt, J = 10.1, 2.1, 1.2 Hz, 1H), 4.07 – 3.94 (m, 1H), 2.44 – 2.25 
(m, 1H), 2.15 (dtdd, J = 14.5, 7.4, 2.6, 1.3 Hz, 1H), 1.77 – 1.66 (m, 2H), 1.30 – 1.10 (m, 3H), 1.05 (t, 
J = 7.6 Hz, 3H); 
13C NMR (101 MHz, CDCl3) δ 138.9, 135.9, 135.8, 135.0, 134.0, 133.9, 129.92, 129.89, 128.3, 
115.5, 63.7, 33.1, 31.7, 7.9, 3.1; 
FT‐IR (thin film) 3436, 3069, 2958, 1428, 1261, 1111, 1011, 912 cm‐1; 
HR‐MS (FAB+) m/z [M+H]+–H2 calcd for C19H23OSi: 295.1518, found: 295.1515. 
 
 
 
1-(Ethyldiphenylsilyl)-3-phenylpropan-1-ol. The title compound was synthesized 
according to General Procedure A from 3-phenylpropanal (0.99 mL g, 7.5 mmol) and 
chloro(ethyl)diphenylsilane (2.47 g, 10.0 mmol). The product was purified by flash 
chromatography (5 → 10% EtOAc in hexanes), which provided 1.21 g (46% yield) of a colorless 
oil. 
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1H NMR (400 MHz, CDCl3) δ 7.62 – 7.52 (m, 4H), 7.46 – 7.33 (m, 6H), 7.31 – 7.25 (m, 2H), 
7.22 – 7.13 (m, 3H), 3.99 (ddd, J = 9.8, 5.3, 3.9 Hz, 1H), 2.94 (ddd, J = 14.1, 8.6, 5.8 Hz, 1H), 2.66 
(ddd, J = 13.6, 8.7, 7.3 Hz, 1H), 2.00 – 1.84 (m, 2H), 1.19 – 1.10 (m, 3H), 1.03 (t, J = 7.6 Hz, 3H); 
13C NMR (101 MHz, CDCl3) δ 142.3, 135.85, 135.79, 133.84, 133.76, 130.0, 129.9, 128.9, 128.7, 
128.32, 128.31, 126.1, 63.6, 35.8, 33.6, 7.8, 3.1; 
FT‐IR (thin film) 3568, 3447, 3067, 2954, 1602, 1496, 1454, 1428, 1379, 1232, 1190, 1111, 1027, 
955, 914 cm‐1; 
HR‐MS (FAB+) m/z [M+H]+–H2 calcd for C23H25OSi: 345.1669, found: 345.1668. 
 
 
 
1-(Ethyldiphenylsilyl)-3-(4-methoxyphenyl)propan-1-ol. The title compound was 
synthesized according to General Procedure A from 3-(4-methoxyphenyl)propanal (1.11 g, 6.8 
mmol) and chloro(ethyl)diphenylsilane (2.22 g, 9.0 mmol). The product was purified by flash 
chromatography (5 → 15% EtOAc in hexanes), which provided 2.20 g (87% yield) of a colorless 
oil. 
1H NMR (400 MHz, CDCl3) δ 7.61–7.51 (m, 4H), 7.45–7.33 (m, 6H), 7.11–7.04 (m, 2H), 6.85–
6.79 (m, 2H), 3.97 (dt, J = 9.8, 4.9 Hz, 1H), 3.79 (s, 3H), 2.87 (ddd, J = 13.9, 8.2, 6.1 Hz, 1H), 2.61 
(dt, J = 13.8, 8.2 Hz, 1H), 1.94–1.83 (m, 2H), 1.20–1.11 (m, 2H), 1.02 (t, J = 7.7 Hz, 3H); 
13C NMR (101 MHz, CDCl3) δ 158.0, 135.8, 135.7, 134.2, 133.8, 133.7, 129.83, 129.81, 129.7, 
128.22, 128.21, 114.0, 63.4, 55.5, 35.8, 32.5, 7.8, 3.0; 
FT‐IR (thin film) 3448, 3068, 2954, 1611, 1517, 1458, 1427, 1300, 1246, 1177, 1110, 1035, 808 
cm‐1; 
HR‐MS (FAB+) m/z [M+H]+–H2 calcd for C24H27O2Si: 375.1780, found: 375.17890. 
 
 
 
3-(4-Chlorophenyl)-1-(ethyldiphenylsilyl)propan-1-ol. The title compound was 
synthesized according to General Procedure A from 3-(4-chlorophenyl)propanal (1.14 g, 6.8 
mmol) and chloro(ethyl)diphenylsilane (2.22 g, 9.0 mmol). The product was purified by flash 
chromatography (5 → 7% EtOAc in hexanes), which provided 1.13 g (44% yield) of a colorless 
oil. 
1H NMR (400 MHz, CDCl3) δ 7.60–7.51 (m, 4H), 7.43–7.33 (m, 6H), 7.23 (d, J = 8.4 Hz, 2H), 
7.08 (d, J = 8.4 Hz, 2H), 3.94 (q, J = 6.3 Hz, 1H), 2.90 (dt, J = 14.0, 7.1 Hz, 1H), 2.64 (dt, J = 14.0, 8.4 
Hz, 1H), 1.93–1.82 (m, 2H), 1.19–1.12 (m, 3H), 1.02 (t, J = 7.6 Hz, 3H); 
 S–6 
13C NMR (101 MHz, CDCl3) δ 140.6, 135.71, 135.66, 133.6, 133.5, 131.7, 130.2, 129.93, 129.91, 
128.7, 128.28, 128.27, 63.2, 35.5, 32.7, 7.7, 3.0; 
FT‐IR (thin film) 3434, 3068, 2956, 1492, 1428, 1260, 1111, 1092, 1015, 808 cm‐1; 
HR‐MS (FAB+) m/z [M+H]+–H2 calcd for C23H24ClOSi: 379.1285, found: 379.1288. 
 
 
 
2-Cyclohexyl-1-(ethyldiphenylsilyl)ethan-1-ol. The title compound was synthesized 
according to General Procedure A from 2-cyclohexylacetaldehyde (0.82 g, 6.5 mmol) and 
chloro(ethyl)diphenylsilane (2.14 g, 8.66 mmol). The product was purified by flash 
chromatography (0 → 5% EtOAc in hexanes), which provided 2.24 g (>99% yield, nominally 
pure) of a pale-yellow oil. 
1H NMR (300 MHz, CDCl3) δ 7.67–7.51 (m, 4H), 7.46–7.31 (m, 6H), 4.15 (ddd, J = 11.4, 5.6, 
2.2 Hz, 1H), 1.90 (d, J = 12.5 Hz, 1H), 1.78–1.45 (m, 7H), 1.42–1.34 (m, 1H), 1.23–1.11 (m, 4H), 
1.08–0.99 (m, 5H), 0.83–0.68 (m, 1H); 
13C NMR (101 MHz, CDCl3) δ 135.8, 135.7, 134.0, 133.9, 129.74, 129.71, 128.2, 128.1, 60.8, 41.4, 
34.9, 34.1, 32.1, 26.9, 26.7, 26.4, 7.7, 3.0; 
FT‐IR (thin film) 3445, 3069, 2913, 1427, 1236, 1189, 1110, 1013, 872 cm‐1; 
HR‐MS (FAB+) m/z [M+H]+ calcd for C22H31OSi: 339.2144, found: 339.2153. 
 
 
 
1-(Ethyldiphenylsilyl)-2-(tetrahydro-2H-pyran-4-yl)ethan-1-ol. The title compound was 
synthesized according to General Procedure A from 2-(tetrahydro-2H-pyran-4-
yl)acetaldehyde (0.87 g, 6.75 mmol) and chloro(ethyl)diphenylsilane (2.22 g, 9.0 mmol). The 
product was purified by flash chromatography (20 → 40% EtOAc in hexanes), which provided 
1.55 g (67% yield) of a colorless oil. 
1H NMR (400 MHz, CDCl3) δ 7.64–7.54 (m, 4H), 7.44–7.34 (m, 6H), 4.14 (ddd, J = 12.0, 5.8, 
2.4 Hz, 1H), 3.96 (ddd, J = 11.3, 4.3, 1.6 Hz, 1H), 3.91 (ddd, J = 11.3, 4.5, 1.6 Hz, 2H), 3.36 (tdd, J = 
11.7, 7.8, 2.2 Hz, 2H), 1.89–1.73 (m, 2H), 1.63–1.56 (m, 1H), 1.54–1.46 (m, 1H), 1.41 (ddd, J = 14.4, 
9.7, 2.3 Hz, 1H), 1.36–1.28 (m, 1H), 1.20–1.13 (m, 2H), 1.05 (t, J = 7.7 Hz, 3H), 1.00 (d, J = 6.0 Hz, 
1H); 
13C NMR (101 MHz, CDCl3) δ 135.63, 135.57, 133.6, 133.4, 129.83, 129.80, 128.184, 128.176, 
68.24, 68.18, 60.2, 40.7, 34.3, 32.0, 31.5, 7.6, 2.8; 
FT‐IR (thin film) 3436, 3068, 2913, 1724, 1428, 1386, 1300, 1261, 1190, 1110, 1013, 872 cm‐1; 
HR‐MS (FAB+) m/z [M+H]+–H2 calcd for C21H27O2Si: 339.1780, found: 339.1774. 
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Tert-butyl 4-(2-(ethyldiphenylsilyl)-2-hydroxyethyl)piperidine-1-carboxylate. The title 
compound was synthesized according to General Procedure A from tert-butyl 4-(2-
oxoethyl)piperidine-1-carboxylate (1.53 g, 6.75 mmol) and chloro(ethyl)diphenylsilane (2.22 g, 
9.0 mmol). The product was purified by flash chromatography (20 → 30% EtOAc in hexanes), 
which provided 2.40 g (81% yield) of a colorless oil. 
1H NMR (400 MHz, CDCl3) δ 7.62–7.53 (m, 4H), 7.46–7.32 (m, 6H), 4.12 (ddd, J = 12.0, 5.8, 
2.2 Hz, 1H), 4.08 (br s, 2H), 2.66 (t, J = 10.6 Hz, 2H), 1.84 (d, J = 12.5 Hz, 1H), 1.79–1.67 (m, 1H), 
1.64–1.50 (m, 2H), 1.44 (s, 9H), 1.39 (ddd, J = 14.4, 9.8, 2.2 Hz, 1H), 1.21–1.08 (m, 3H), 1.04 (t, J = 
7.6 Hz, 3H), 1.07–1.01 (m, 1H), 1.01–0.95 (m, 1H); 
13C NMR (101 MHz, CDCl3) δ 155.1, 135.7, 135.6, 133.6, 133.5, 129.92, 129.89, 128.3, 79.4, 60.6, 
44.2 (br), 40.4, 33.5, 32.6, 31.1, 28.7, 7.7, 2.9; 
FT‐IR (thin film) 3447, 3069, 2916, 1694, 1668, 1428, 1366, 1279, 1246, 1167, 1111, 1011, 974, 
869 cm‐1; 
HR‐MS (FAB+) m/z [M+H]+ calcd for C26H38NO3Si: 440.2621, found: 440.2632. 
 
 
 
1-(Ethyldiphenylsilyl)-3-(5-methylfuran-2-yl)propan-1-ol. The title compound was 
synthesized according to General Procedure A from 3-(5-methylfuran-2-yl)propanal (0.95 mL, 
7.1 mmol) and chloro(ethyl)diphenylsilane (2.35 g, 9.5 mmol). The product was purified by 
flash chromatography (5 → 10% EtOAc in hexanes), which provided 1.94 g (77% yield) of a 
colorless oil. 
1H NMR (400 MHz, CDCl3) δ 7.66–7.51 (m, 4H), 7.48–7.30 (m, 6H), 5.88–5.80 (m, 2H), 3.98 
(dd, J = 11.5, 2.6 Hz, 1H), 2.85 (ddd, J = 13.6, 8.2, 5.2 Hz, 1H), 2.69 (dt, J = 15.5, 7.8 Hz, 1H), 2.27 
(s, 3H), 2.03–1.92 (m, 1H), 1.91–1.78 (m, 1H), 1.44 (br s, 1H), 1.23–1.13 (m, 2H), 1.04 (t, J = 7.8 
Hz, 3H); 
13C NMR (101 MHz, CDCl3) δ 154.0, 150.6, 135.73, 135.67, 133.73, 133.67, 129.82, 129.79, 
128.19, 128.18, 106.1, 106.0, 63.3, 32.4, 25.7, 13.8, 7.7, 3.0; 
FT‐IR (thin film) 3293, 3070, 2959, 1590, 1458, 1428, 1261, 1118, 1012, 829 cm‐1; 
HR‐MS (FAB+) m/z [M+H]+ calcd for C22H27O2Si: 351.1780, found: 351.1782. 
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1-(Methyldiphenylsilyl)-3-phenylpropan-1-ol. The title compound was synthesized 
according to General Procedure A from 3-phenylpropanal (0.94 mL, 7.1 mmol) and 
chloro(methyl)diphenylsilane (2.00 mL, 9.5 mmol). The product was purified by flash 
chromatography (5 → 10% EtOAc in hexanes), which provided 2.09 g (88% yield) of a colorless 
oil. 
1H NMR (400 MHz, CDCl3) δ 7.57 – 7.49 (m, 4H), 7.46 – 7.32 (m, 6H), 7.31 – 7.25 (m, 2H), 
7.22 – 7.14 (m, 3H), 3.93 (dd, J = 8.9, 5.3 Hz, 1H), 2.95 (ddd, J = 14.1, 8.5, 6.4 Hz, 1H), 2.66 (dt, J = 
13.6, 8.1 Hz, 1H), 2.02 – 1.85 (m, 2H), 1.19 (s, 1H), 0.61 (s, 3H); 
13C NMR (101 MHz, CDCl3) δ 142.3, 135.4, 135.3, 135.1, 134.8, 130.00, 129.96, 128.9, 128.7, 
128.37, 128.36, 126.1, 64.2, 35.5, 33.6, –6.4; 
FT‐IR (thin film) 3566, 3443, 3068, 2924, 1602, 1496, 1454, 1428,1253, 1112, 1028, 914 cm‐1; 
HR‐MS (FAB+) m/z [M+H]+ calcd for C22H25OSi: 333.1675, found: 333.1680. 
 
 
General Procedure B: Preparation of -(dithiane)silanes (for substrates that lack an aryl 
substituent on silicon). The method of Christmann was used.6 
 
 
(1,3-Dithian-2-yl)triethylsilane. The title compound was synthesized according to General 
Procedure B from chlorotriethylsilane (16.8 mL, 100 mmol). The product was purified by high-
vacuum distillation, which provided 16.9 g (87% yield) of a colorless oil. 
1H NMR (400 MHz, CDCl3) δ 3.82 (s, 1H), 2.94 – 2.83 (m, 2H), 2.78 – 2.66 (m, 2H), 2.18 – 1.95 
(m, 2H), 1.01 (t, J = 7.9 Hz, 9H), 0.70 (q, J = 7.9, 6H); 
13C NMR (101 MHz, CDCl3) δ 32.5, 31.8, 26.8, 7.8, 2.5; 
FT‐IR (thin film) 2951, 2875, 1458, 1420, 1260, 1240, 1163, 1084, 1019, 778 cm‐1; 
HR‐MS (FAB+) m/z [M+H]+–H2 calcd for C10H21S2Si: 233.0854, found: 233.0846. 
 
 
  
                                                 
(6) Winter, P.; Hiller, W.; Christmann, M. Angew. Chem. Int. Ed. 2012, 51, 3396–3400. 
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Tert-butyl(1,3-dithian-2-yl)dimethylsilane.7 The title compound was synthesized 
according to General Procedure B from tert-butyl(chloro)dimethylsilane (15.1 g, 100 mmol). 
The product was purified by high-vacuum distillation, which provided 16.2 g (83 yield) of a 
pale-purple oil. 
1H NMR (300 MHz, CDCl3) δ 3.80 (s, 1H), 2.98 – 2.76 (m, 2H), 2.69 (ddd, J = 14.0, 4.1, 3.1 Hz, 
2H), 2.17 – 1.90 (m, 2H), 0.96 (d, J = 0.6 Hz, 9H), 0.10 (d, J = 0.5 Hz, 6H). 
 
 
 
General Procedure C: Preparation of acylsilanes (for substrates that lack an aryl 
substituent on silicon). The alkylation of α-dithiane silanes was performed according to a 
literature procedure.8 In a flame-dried round-bottom flask, n-BuLi (1.05 equiv) was added 
dropwise to a stirring solution of the α-dithiane silane (1.00 equiv) in THF (0.4 M with respect 
to the α-dithiane silane) at room temperature under an atmosphere of nitrogen. The solution 
was stirred for 10 min at room temperature, and then it was cooled to –40 °C. Next, (2-
bromoethyl)benzene (1.10 equiv) was added dropwise over 1–2 min. The reaction mixture was 
then warmed to room temperature and stirred for 2 h. Next, the reaction was quenched 
through the addition of a saturated aqueous solution of NH4Cl. The resulting mixture was 
extracted with Et2O three times, and the organic phases were collected, dried over MgSO4, 
filtered, and concentrated. This material was used in the next step without further purification. 
The deprotection of the α-alkyl-α-dithiane silanes was performed according to a literature 
procedure.2 In a round-bottom flask, the α-alkyl-α-dithiane silane was dissolved in a 4:1 
mixture of THF/H2O (0.9 M with respect to the α-dithiane silane). The solution was cooled to 0 
°C, and then CaCO3 (15.6 equiv) was added, followed by I2 (12.0 equiv; added in portions). The 
reaction was warmed to room temperature and stirred for 16 h. The reaction mixture was 
diluted with Et2O (15 mL/mmol of α-dithiane silane), and the reaction was quenched by the 
addition of a saturated solution of Na2S2O3. The biphasic mixture was filtered through Celite 
and transferred to a separatory funnel (note: if the color of iodine remains, the organic layer 
was washed with an additional quantity of the saturated solution of Na2S2O3). The organic 
layer was separated, dried over MgSO4, filtered, and concentrated. The acyl silane can be used 
in General Procedure D without further purification. 
                                                 
(7) Scheller, M. E.; Frei, B. Helv. Chim. Acta. 1984, 67, 1734–1747. 
(8) Smith, A. B., III; Xian, M.; Kim, W.-S.; Kim, D.-S. J. Am. Chem. Soc. 2006, 128, 12368–12369. 
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SS SS
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3-Phenyl-1-(triethylsilyl)propan-1-one.9 The title compound was synthesized according to 
General Procedure C from (1,3-dithian-2-yl)triethylsilane (2.13 g, 9.10 mmol). The product was 
purified by flash chromatography (0 → 3% EtOAc in hexanes), which provided 1.08 g (48% 
yield over two steps) of a colorless oil. 
1H NMR (300 MHz, CDCl3) δ 7.31 – 7.24 (m, 2H), 7.22 – 7.13 (m, 3H), 2.95 – 2.76 (m, 4H), 
0.96 (t, J = 7.8 Hz, 9H), 0.73 (q, J = 7.9 Hz, 6H). 
 
 
 
1-(Tert-butyldimethylsilyl)-3-phenylpropan-1-one.10 The title compound was synthesized 
according to General Procedure C from tert-butyl(1,3-dithian-2-yl)dimethylsilane (4.00 g, 17.1 
mmol). The product was purified by flash chromatography (0 → 2% EtOAc in hexanes), which 
provided 4.25 g (>99% yield of nominally pure material over two steps) of a white solid. 
1H NMR (300 MHz, CDCl3) δ 7.40 – 7.30 (m, 2H), 7.30 – 7.20 (m, 3H), 3.07 – 2.78 (m, 4H), 
0.99 (s, 9H), 0.25 (s, 6H). 
 
 
General Procedure D: Reduction of acylsilanes (for substrates that lack an aryl 
substituent on silicon). In a round-bottom flask charged with a stir bar, LiAlH4 (4.9 equiv) was 
slowly dissolved in THF (~40 mL/mmol of acyl silane) at 0 °C. The resulting solution was 
stirred for 10 min. A solution of the acyl silane in THF (~1.5 mL/mmol of acyl silane) was 
added in a slow, steady stream to the solution of LiAlH4 at 0 °C. Next, the reaction mixture 
was warmed to room temperature and stirred for 3 h. The reaction was then quenched and 
worked up using the Fieser method. 
 
  
                                                 
(9) Reddy, G. P.; Reddy, J. S.; Das, S.; Roisnel, T.; Yadav, J. S.; Chandrasekhar, S.; Gree, R. 
Org. Lett. 2013, 15, 1524–1527. 
(10) Reich, H. J.; Holtan, R. C.; Bolm, C. J. Am. Chem. Soc. 1990, 112, 5609–5617. 
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3-Phenyl-1-(trimethylsilyl)propan-1-ol.11 The title compound was synthesized according 
to General Procedure D from 3-phenyl-1-(trimethylsilyl)propan-1-one (1.84 g, 9.8 mmol). The 
product was purified by flash chromatography (5 → 10% EtOAc in hexanes), which provided 
1.65 g (89% yield) of a colorless oil. 
1H NMR (400 MHz, CDCl3) δ 7.34 – 7.27 (m, 2H), 7.25 – 7.17 (m, 3H), 3.39 – 3.29 (m, 1H), 
2.99 – 2.87 (m, 1H), 2.71 – 2.61 (m, 1H), 1.91 – 1.74 (m, 2H), 1.11 (s, 1H), 0.05 (s, 9H). 
 
 
 
3-Phenyl-1-(triethylsilyl)propan-1-ol. The title compound was synthesized according to 
General Procedure D from 3-phenyl-1-(triethylsilyl)propan-1-one (1.08 g, 4.35 mmol). The 
product was purified by flash chromatography (5% EtOAc in hexanes), which provided 0.82 g 
(75% yield) of a colorless oil. 
1H NMR (400 MHz, CDCl3) δ 7.33 – 7.26 (m, 2H), 7.24 – 7.12 (m, 3H), 3.51 (dd, J = 11.2, 2.9 
Hz, 1H), 2.96 (ddd, J = 13.7, 9.8, 5.0 Hz, 1H), 2.66 (tdd, J = 13.6, 8.7, 6.9 Hz, 1H), 1.96 – 1.75 (m, 
2H), 1.50 (s, 1H), 1.03 – 0.93 (m, 9H), 0.68 – 0.49 (m, 6H); 
13C NMR (101 MHz, CDCl3) δ 140.6, 126.83, 126.77, 124.1, 62.5, 34.3, 31.9, 5.9, 0.0; 
FT‐IR (thin film) 3448, 3026, 2953, 1708, 1604, 1496, 1455, 1415, 1260, 1239, 1018, 912 cm‐1; 
HR‐MS (FAB+) m/z [M+H]+–H2 calcd for C15H25OSi: 249.1675, found: 249.1679. 
 
 
 
1-(Tert-butyldimethylsilyl)-3-phenylpropan-1-ol. The title compound was synthesized 
according to General Procedure D from 1-(tert-butyldimethylsilyl)-3-phenylpropan-1-one 
(2.49 g, 10.0 mmol). The product was purified by flash chromatography (0 → 15% EtOAc in 
hexanes), which provided 1.75 g (70% yield) of a colorless oil. 
1H NMR (400 MHz, CDCl3) δ 7.34 – 7.27 (m, 2H), 7.25 – 7.15 (m, 3H), 3.53 (dd, J = 9.8, 4.2 
Hz, 1H), 2.96 (ddd, J = 13.6, 9.0, 6.0 Hz, 1H), 2.65 (ddd, J = 13.5, 8.9, 7.2 Hz, 1H), 1.96 – 1.77 (m, 
2H), 1.08 (s, 1H), 0.94 (s, 9H), 0.02 (s, 3H), –0.04 (s, 3H); 
13C NMR (101 MHz, CDCl3) δ 142.6, 128.82, 128.77, 126.2, 64.4, 36.7, 33.8, 27.4, 17.1, –7.2,  
–8.2; 
FT‐IR (thin film) 3467, 3027, 2954, 1604, 1496, 1471, 1362, 1255, 1024, 914, 832 cm‐1; 
HR‐MS (FAB+) m/z [M+H]+–H2 calcd for C15H25OSi: 249.1675, found: 249.1673. 
                                                 
(11) Goddard, J.-P.; Le Gall, T.; Mioskowski, C. Org. Lett. 2000, 2, 1455–1456. 
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General Procedure E: Preparation of α-bromosilanes. PPh3 (1.50 equiv) and imidazole 
(1.50 equiv) were dissolved in CH2Cl2 (6.0 mL/mmol of α-hydroxysilane), and the resulting 
solution was cooled to 0 °C. At this temperature, I2 (1.50 equiv) was added in portions, and the 
resulting mixture was stirred for 10 min. Next, a solution of the α-hydroxysilane (1.00 equiv) 
in CH2Cl2 (4.0 mL/mmol) was added in a steady stream, and the resulting mixture was 
allowed to warm to room temperature and stirred overnight. Then, the reaction mixture was 
quenched with H2O and then extracted with EtOAc. The organic layer was dried over Na2SO4, 
filtered, and concentrated. The filtrate was concentrated in vacuo, and the residue was purified 
by flash chromatography on silica gel to afford the pure product.  
 
 
 
(1-Bromohexyl)(ethyl)diphenylsilane. The title compound was synthesized according to 
General Procedure E from 1-(ethyldiphenylsilyl)hexan-1-ol (1.60 g, 5.1 mmol). The product 
was purified by flash chromatography (2 → 5% EtOAc in hexanes), which provided 1.46 g 
(76% yield) of a colorless oil. 
1H NMR (400 MHz, CDCl3) δ 7.66–7.54 (m, 4H), 7.49–7.34 (m, 6H), 3.81 (dd, J = 11.9, 2.7 Hz, 
1H), 1.94–1.81 (m, 1H), 1.79–1.62 (m, 2H), 1.47–1.35 (m, 1H), 1.35–1.22 (m, 5H), 1.22–1.12 (m, 
1H), 1.04 (t, J = 7.8 Hz, 3H), 0.87 (t, J = 7.0 Hz, 3H); 
13C NMR (101 MHz, CDCl3) δ 136.0, 135.8, 133.5, 133.0, 130.0, 129.9, 128.1, 128.0, 41.2, 33.6, 
31.1, 29.1, 22.8, 14.3, 7.6, 4.4; 
FT‐IR (thin film) 3070, 2959, 1458, 1428, 1261, 1106, 1029, 802 cm‐1; 
HR‐MS (FAB+) m/z [M]+ calcd for C20H2779BrSi: 374.1065, found: 374.1060. 
 
 
 
(1-Bromo-2-phenylethyl)(ethyl)diphenylsilane. The title compound was synthesized 
according to General Procedure E from 1-(ethyldiphenylsilyl)-2-phenylethan-1-ol (0.70 g, 2.11 
mmol). The product was purified by flash chromatography (20% CHCl3 in hexanes), which 
provided 0.64 g (76% yield) of a colorless oil. 
1H NMR (400 MHz, CDCl3) δ 7.74 – 7.60 (m, 4H), 7.52 – 7.38 (m, 6H), 7.32 – 7.21 (m, 3H), 
7.20 – 7.15 (m, 2H), 3.98 (dd, J = 12.3, 2.7 Hz, 1H), 3.36 (dd, J = 15.2, 2.6 Hz, 1H), 2.86 (dd, J = 
15.1, 12.3 Hz, 1H), 1.41 – 1.19 (m, 2H), 1.13 – 0.99 (m, 3H); 
13C NMR (101 MHz, CDCl3) δ 140.4, 136.1, 135.9, 133.2, 132.7, 130.3, 130.2, 129.1, 128.6, 128.4, 
128.3, 126.9, 40.9, 40.0, 7.7, 4.6; 
FT‐IR (thin film) 3068, 2962, 1588, 1496, 1454, 1427, 1261, 1105, 1030, 801 cm‐1; 
HR‐MS (FAB+) m/z [M]+ calcd for C22H2379BrSi: 394.0752, found: 394.0762. 
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(1-Bromopent-4-en-1-yl)(ethyl)diphenylsilane. The title compound was synthesized 
according to General Procedure E from 1-(ethyldiphenylsilyl)pent-4-en-1-ol (1.06 g, 3.58 
mmol). The product was purified by flash chromatography (5 → 20% CHCl3 in hexanes), 
which provided 0.87 g (68% yield) of a colorless oil. 
1H NMR (400 MHz, CDCl3) δ 7.65 – 7.55 (m, 4H), 7.48 – 7.35 (m, 6H), 5.72 (dddd, J = 17.1, 
10.1, 7.7, 5.9 Hz, 1H), 5.11 – 4.98 (m, 2H), 3.83 (dd, J = 12.3, 2.5 Hz, 1H), 2.49 – 2.33 (m, 1H), 2.27 
– 2.15 (m, 1H), 2.01 – 1.89 (m, 1H), 1.80 (dddd, J = 14.9, 12.3, 7.8, 4.5 Hz, 1H), 1.36 – 1.19 (m, 2H), 
1.07 – 0.98 (m, 3H); 
13C NMR (101 MHz, CDCl3) δ 137.3, 136.1, 135.9, 133.4, 132.9, 130.13, 130.08, 128.24, 128.18, 
116.5, 40.0, 33.2, 32.8, 7.6, 4.5; 
FT‐IR (thin film) 3070, 2961, 1640, 1589, 1488, 1428, 1261, 1110, 1028, 916, 803 cm‐1; 
HR‐MS (FAB+) m/z [M]+ calcd for C19H2379BrSi: 358.0752, found: 358.0746. 
 
 
 
(1-Bromo-3-phenylpropyl)(ethyl)diphenylsilane. The title compound was synthesized 
according to General Procedure E from 1-(ethyldiphenylsilyl)-3-phenylpropan-1-ol (1.21 g, 
3.49 mmol). The product was purified by flash chromatography (0 → 5% EtOAc in hexanes), 
which provided 1.07 g (75% yield) of a colorless oil. 
1H NMR (400 MHz, CDCl3) δ 7.59 – 7.53 (m, 2H), 7.49 – 7.26 (m, 10H), 7.25 – 7.19 (m, 1H), 
7.18 – 7.11 (m, 2H), 3.72 (dd, J = 12.2, 2.2 Hz, 1H), 3.00 (ddd, J = 13.8, 7.9, 4.3 Hz, 1H), 2.73 (dt, J 
= 13.6, 8.1 Hz, 1H), 2.24 – 2.11 (m, 1H), 2.01 (dddd, J = 15.0, 12.1, 7.8, 4.3 Hz, 1H), 1.31 – 1.16 (m, 
2H), 1.03 – 0.88 (m, 3H); 
13C NMR (101 MHz, CDCl3) δ 140.8, 135.7, 135.5, 133.0, 132.4, 129.8, 129.7, 128.8, 128.4, 
127.87, 127.86, 126.1, 39.3, 35.1, 34.7, 7.2, 4.2; 
FT‐IR (thin film) 3069, 2961, 1589, 1496, 1454, 1428, 1261, 1110, 802 cm‐1; 
HR‐MS (FAB+) m/z [M–C2H5]+ calcd for C21H2079BrSi: 379.0518, found: 379.0504. 
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(1-Bromo-3-(4-methoxyphenyl)propyl)(ethyl)diphenylsilane. The title compound was 
synthesized according to General Procedure E from 1-(ethyldiphenylsilyl)-3-(4-
methoxyphenyl)propan-1-ol (2.20 g, 5.8 mmol). The product was purified by flash 
chromatography (0 → 5% EtOAc in hexanes), which provided 1.68 g (65% yield) of a colorless 
oil. 
1H NMR (300 MHz, CDCl3) δ 7.65–7.58 (m, 2H), 7.55–7.49 (m, 2H), 7.49–7.34 (m, 6H), 7.17–
7.08 (m, 2H), 6.93–6.85 (m, 2H), 3.84 (s, 3H), 3.77 (dd, J = 12.1, 2.3 Hz, 1H), 2.97 (ddd, J = 13.6, 
7.4, 4.3 Hz, 1H), 2.74 (dt, J = 13.8, 8.2 Hz, 1H), 2.19 (dtd, J = 15.1, 7.8, 2.2 Hz, 1H), 2.03 (dddd, J = 
15.0, 12.0, 7.6, 4.3 Hz, 1H), 1.39–1.24 (m, 2H), 1.03 (t, J = 7.7 Hz, 3H); 
13C NMR (101 MHz, CDCl3) δ 158.2, 135.9, 135.7, 133.2, 133.0, 132.6, 130.00, 129.95, 129.9, 
128.1, 128.0, 114.0, 55.4, 39.5, 35.5, 33.9, 7.5, 4.4; 
FT‐IR (thin film) 3070, 2955, 1611, 1512, 1428, 1301, 1247, 1177, 1111, 1037, 807 cm‐1; 
HR‐MS (FAB+) m/z [M]+ calcd for C24H2781BrOSi: 440.0991, found: 440.0997. 
 
 
 
(1-Bromo-3-(4-chlorophenyl)propyl)(ethyl)diphenylsilane. The title compound was 
synthesized according to General Procedure E from 3-(4-chlorophenyl)-1-
(ethyldiphenylsilyl)propan-1-ol (1.13 g, 2.97 mmol). The product was purified by flash 
chromatography (5 → 10% EtOAc in hexanes), which provided 0.63 g (48% yield) of a colorless 
oil. 
1H NMR (400 MHz, CDCl3) δ 7.60–7.54 (m, 2H), 7.49–7.32 (m, 8H), 7.26 (d, J = 8.4 Hz, 2H), 
7.08 (d, J = 8.4 Hz, 2H), 3.67 (dd, J = 12.2, 2.3 Hz, 1H), 2.95 (ddd, J = 13.7, 7.6, 4.2 Hz, 1H), 2.72 
(dt, J = 13.8, 8.0 Hz, 1H), 2.13 (dddd, J = 15.1, 8.6, 7.7, 2.2 Hz, 1H), 1.99 (dddd, J = 15.1, 12.1, 7.6, 
4.3 Hz, 1H), 1.31–1.21 (m, 2H), 0.99 (t, J = 7.8 Hz, 3H); 
13C NMR (101 MHz, CDCl3) δ 139.4, 135.9, 135.7, 133.1, 132.5, 132.1, 130.4, 130.1, 130.0, 128.8, 
128.14, 128.12, 39.2, 35.1, 34.2, 7.5, 4.3; 
FT‐IR (thin film) 3069, 2955, 1589, 1492, 1428, 1262, 1218, 1152, 1112, 1015, 998, 956, 843, 812 
cm‐1; 
HR‐MS (FAB+) m/z [M–Br]+ calcd for C23H24ClSi: 363.1336, found: 363.1333. 
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(1-Bromo-2-cyclohexylethyl)(ethyl)diphenylsilane. The title compound was synthesized 
according to General Procedure E from 2-cyclohexyl-1-(ethyldiphenylsilyl)ethan-1-ol (2.24 g, 
6.6 mmol). The product was purified by flash chromatography (0 → 5% EtOAc in hexanes), 
which provided 1.58 g (59% yield) of a colorless oil. 
1H NMR (300 MHz, CDCl3) δ 7.65–7.48 (m, 4H), 7.45–7.33 (m, 6H), 3.96 (dd, J = 12.4, 2.1 Hz, 
1H), 1.92 (d, J = 12.5 Hz, 1H), 1.78–1.59 (m, 5H), 1.59–1.47 (m, 1H), 1.33–1.07 (m, 6H), 1.02 (t, J = 
7.8 Hz, 3H), 0.93–0.80 (m, 1H), 0.71 (qd, J = 12.4, 3.4 Hz, 1H); 
13C NMR (101 MHz, CDCl3) δ 136.0, 135.8, 133.5, 132.9, 130.0, 129.9, 128.1, 128.0, 40.9, 37.8, 
35.7, 34.3, 31.2, 26.8, 26.5, 26.2, 7.5, 4.4; 
FT‐IR (thin film) 3069, 2923, 1589, 1488, 1448, 1428, 1261, 1110, 1029, 803 cm‐1; 
HR‐MS (EI+) m/z [M]+ calcd for C22H2979BrSi: 400.1222, found: 400.1251. 
 
 
 
(1-Bromo-2-(tetrahydro-2H-pyran-4-yl)ethyl)(ethyl)diphenylsilane. The title compound 
was synthesized according to General Procedure E from 1-(ethyldiphenylsilyl)-2-(tetrahydro-
2H-pyran-4-yl)ethan-1-ol (1.55 g, 4.6 mmol). The product was purified by flash 
chromatography (3 → 5% EtOAc in hexanes), which provided 1.25 g (68% yield) of a colorless 
oil. 
1H NMR (400 MHz, CDCl3) δ 7.63–7.53 (m, 4H), 7.48–7.34 (m, 6H), 3.98 (dd, J = 11.4, 4.2 Hz, 
1H), 3.92 (dd, J = 12.9, 2.3 Hz, 1H), 3.89 (dd, J = 11.4, 4.4 Hz, 1H), 3.38 (dtd, J = 16.8, 11.9, 2.3 Hz, 
2H), 1.99–1.85 (m, 1H), 1.84–1.70 (m, 2H), 1.62 (ddd, J = 15.0, 10.0, 2.4 Hz, 1H), 1.49–1.40 (m, 
1H), 1.34–1.18 (m, 3H), 1.11 (td, J = 12.1, 4.5 Hz, 1H), 1.02 (t, J = 7.8 Hz, 3H); 
13C NMR (101 MHz, CDCl3) δ 136.0, 135.8, 133.2, 132.6, 130.1, 130.0, 128.2, 128.1, 68.2, 68.1, 
40.3, 36.7, 33.7, 33.2, 31.2, 7.5, 4.4; 
FT‐IR (thin film) 3070, 2929, 1428, 1190, 1111, 1012, 849 cm‐1; 
HR‐MS (FAB+) m/z [M+H]+–H2 calcd for C21H2679BrOSi: 401.0936, found: 401.0918. 
 
 
 
Tert-butyl 4-(2-bromo-2-(ethyldiphenylsilyl)ethyl)piperidine-1-carboxylate. The title 
compound was synthesized according to General Procedure E from tert-butyl 4-(2-
(ethyldiphenylsilyl)-2-hydroxyethyl)piperidine-1-carboxylate (2.40 g, 5.5 mmol). The product 
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was purified by flash chromatography (3 → 7% EtOAc in hexanes), which provided 2.02 g 
(74% yield) of a colorless oil. 
1H NMR (400 MHz, CDCl3) δ 7.64–7.53 (m, 4H), 7.48–7.36 (m, 6H), 4.13 (br s, 1H), 4.04 (br s, 
1H), 3.92 (dd, J = 12.8, 2.1 Hz, 1H), 2.69 (q, J = 11.5 Hz, 2H), 1.95–1.73 (m, 3H), 1.60 (ddd, J = 
14.8, 9.7, 2.2 Hz, 1H), 1.55–1.47 (m, 1H), 1.45 (s, 9H), 1.32–1.24 (m, 2H), 1.16–1.06 (m, 1H), 1.03 
(t, J = 7.9 Hz, 3H), 0.96–0.89 (m, 1H); 
13C NMR (101 MHz, CDCl3) δ 155.0, 135.9, 135.7, 133.1, 132.5, 130.1, 130.0, 128.2, 128.1, 79.5, 
43.9 (br; two carbons), 40.0, 37.0, 34.3, 32.9, 30.2, 28.7, 7.5, 4.3; 
FT‐IR (thin film) 3070, 2931, 1694, 1428, 1365, 1261, 1162, 1111, 1026, 865 cm‐1; 
HR‐MS (FAB+) m/z [M+H]+–H2 calcd for C26H3579BrNO2Si: 500.1620, found: 500.1618. 
 
 
 
(1-Bromo-3-(5-methylfuran-2-yl)propyl)(ethyl)diphenylsilane. The title compound was 
synthesized according to General Procedure E from 1-(ethyldiphenylsilyl)-3-(5-methylfuran-2-
yl)propan-1-ol (1.94 g, 5.5 mmol). The product was purified by flash chromatography (0 → 5% 
EtOAc in hexanes), which provided 1.14 g (50% yield) of a colorless oil. 
1H NMR (400 MHz, CDCl3) δ 7.63–7.55 (m, 2H), 7.55–7.48 (m, 2H), 7.48–7.30 (m, 6H), 5.94–
5.80 (m, 2H), 3.76 (dd, J = 12.4, 2.0 Hz, 1H), 2.90 (ddd, J = 15.1, 7.0, 4.5 Hz, 1H), 2.77 (ddd, J = 
15.7, 8.6, 7.4 Hz, 1H), 2.26 (s, 3H), 1.92 (dddd, J = 15.1, 12.4, 7.1, 4.2 Hz, 1H), 1.31–1.24 (m, 2H), 
0.99 (t, J = 7.8 Hz, 3H); 
13C NMR (101 MHz, CDCl3) δ 152.7, 150.9, 136.0, 135.8, 133.2, 132.6, 130.05, 129.96, 128.10, 
128.08, 107.0, 106.1, 39.4, 32.3, 27.4, 13.8, 7.4, 4.4; 
FT‐IR (thin film) 3070, 2960, 1568, 1428, 1261, 1109, 1020, 800 cm‐1; 
HR‐MS (FAB+) m/z [M+H]+ calcd for C22H2579BrOSi: 412.0858, found: 412.0840. 
 
 
 
(1-Bromo-3-phenylpropyl)(methyl)diphenylsilane. The title compound was synthesized 
according to General Procedure E from 1-(methyldiphenylsilyl)-3-phenylpropan-1-ol (1.00 g, 
3.01 mmol). The product was purified by flash chromatography (0 → 5% EtOAc in hexanes), 
which provided 2.03 g (86% yield) of a colorless oil. 
1H NMR (400 MHz, CDCl3) δ 7.55 – 7.48 (m, 4H), 7.46 – 7.27 (m, 8H), 7.24 – 7.17 (m, 1H), 
7.17 – 7.10 (m, 2H), 3.68 (dd, J = 11.8, 2.7 Hz, 1H), 3.01 (ddd, J = 12.9, 8.0, 4.4 Hz, 1H), 2.77 – 2.69 
(m, 1H), 2.23 – 1.97 (m, 2H), 0.71 (s, 3H); 
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13C NMR (101 MHz, CDCl3) δ 141.1, 135.4, 135.3, 134.6, 134.3, 130.13, 130.07, 129.1, 128.8, 
128.3, 128.2, 126.4, 40.7, 35.4, 35.1, –5.2; 
FT‐IR (thin film) 3069, 2962, 1603, 1589, 1496, 1454, 1428, 1260, 1113, 1029, 998 cm‐1; 
HR‐MS (FAB+) m/z [M–C6H6]+ calcd for C16H1779BrSi: 316.0283, found: 316.0296. 
 
 
 
(1-Bromo-3-phenylpropyl)trimethylsilane. The title compound was synthesized according 
to General Procedure E from 3-phenyl-1-(trimethylsilyl)propan-1-ol (1.65 g, 7.9 mmol). The 
product was purified by flash chromatography (0 → 1% EtOAc in hexanes), which provided 
1.80 g (84% yield) of a colorless oil. 
1H NMR (400 MHz, CDCl3) δ 7.36 – 7.28 (m, 2H), 7.27 – 7.20 (m, 3H), 3.23 (dd, J = 11.5, 3.3 
Hz, 1H), 3.08 (ddd, J = 13.3, 8.4, 4.7 Hz, 1H), 2.76 (ddd, J = 13.6, 8.7, 7.6 Hz, 1H), 2.17 – 1.94 (m, 
2H), 0.15 (s, 9H); 
13C NMR (101 MHz, CDCl3) δ 141.5, 129.0, 128.8, 126.3, 44.6, 35.54, 35.46, –2.7; 
FT‐IR (thin film) 3027, 2955, 1604, 1496, 1454, 1250, 1110, 1075, 1030, 867, 840 cm‐1; 
HR‐MS (EI+) m/z [M]+ calcd for C12H1979BrSi: 270.0439, found: 270.0419. 
 
 
 
(1-Bromo-3-phenylpropyl)triethylsilane. The title compound was synthesized according 
to General Procedure E from 3-phenyl-1-(triethylsilyl)propan-1-ol (4.8 g, 19.3 mmol). The 
product was purified by flash chromatography (0 → 2% EtOAc in hexanes), which provided 
3.38 g (56% yield) of a colorless oil. 
1H NMR (400 MHz, CDCl3) δ 7.33 – 7.27 (m, 2H), 7.25 – 7.18 (m, 3H), 3.37 – 3.27 (m, 1H), 
3.07 (ddd, J = 13.3, 7.3, 5.5 Hz, 1H), 2.71 (dt, J = 13.6, 8.1 Hz, 1H), 2.14 – 1.98 (m, 2H), 0.96 (t, J = 
7.9 Hz, 9H), 0.68 (q, J = 7.4, 6H); 
13C NMR (101 MHz, CDCl3) δ 141.5, 129.0, 128.8, 126.3, 42.1, 35.9, 35.7, 7.8, 2.9; 
FT‐IR (thin film) 3027, 2955, 1604, 1496, 1454, 1415, 1260, 1096, 1019, 804 cm‐1; 
HR‐MS (FAB+) m/z [M]+ calcd for C15H2579BrSi: 312.0909, found: 312.0918. 
 
 
 
(1-Bromo-3-phenylpropyl)(tert-butyl)dimethylsilane. The title compound was 
synthesized according to General Procedure E from 1-(tert-butyldimethylsilyl)-3-
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phenylpropan-1-ol (2.00 g, 8.00 mmol). The product was purified by flash chromatography (0 
→ 1% EtOAc in hexanes), which provided 1.94 g (77% yield) of a colorless oil. 
1H NMR (400 MHz, CDCl3) δ 7.33 – 7.28 (m, 2H), 7.25 – 7.18 (m, 3H), 3.34 (dd, J = 11.8, 2.8 
Hz, 1H), 3.07 (ddd, J = 13.3, 8.5, 4.5 Hz, 1H), 2.74 (ddd, J = 13.5, 8.7, 7.6 Hz, 1H), 2.22 – 1.96 (m, 
2H), 0.93 (s, 9H), 0.13 (s, 3H), 0.07 (s, 3H); 
13C NMR (101 MHz, CDCl3) δ 141.5, 129.0, 128.8, 126.4, 42.6, 36.7, 35.6, 27.7, 17.9, –5.6, –6.9; 
FT‐IR (thin film) 3027, 2958, 2930, 1604, 1496, 1470, 1364, 1259, 1096, 1030, 823 cm‐1; 
HR‐MS (FAB+) m/z [M–C(CH)3]+ calcd for C11H1679BrSi: 255.0205, found: 255.0208. 
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III.  Cross-Couplings 
 
Preparation of alkylzinc reagent. An oven-dried 40 mL vial was charged with Zn0 powder 
(3.0 equiv) and a cross-shaped stir bar. The vial was then sealed with a pierceable septum cap 
and placed under vacuum on a Schlenk line. Next, the vial was heated with a heat gun for ~4 
min, and then it was allowed to cool to room temperature under vacuum. With the aid of an 
argon-filled balloon, the vial was placed under an argon atmosphere, and then anhydrous 
DMA was added (1.0 mL/mmol of alkyl bromide, including the 1.0 mL used for the solution of 
I2). To this stirring suspension of Zn0 powder was added a solution of I2 (0.050 equiv in 1.0 mL 
of DMA); the mixture was allowed to stir until the yellow color dissipated. Then, the alkyl 
bromide (1.0 equiv) was added, vacuum grease was applied to the septum punctures to 
minimize leakage, and the reaction mixture was warmed to 50 °C and stirred for 16 h. After 
cooling to room temperature, the argon-filled balloon was removed, and the reaction mixture 
was brought into a glovebox. The suspension was passed through syringe filters (1-micron and 
then 0.45-micron) to remove residual zinc powder. The alkylzinc bromide solution (can range 
from nearly colorless to dark red or dark green) was then titrated with a known amount of I2 in 
THF (1.0 mL).12 
 
General Procedure. An oven-dried 4-mL vial was charged with the α-bromosilane (0.50 
mmol), followed by NiBr2diglyme (15.4 mg, 0.050 mmol) and then L* (21.4 mg, 0.065 mmol). 
Next, an oven-dried stir bar was added, and the reaction vial was capped with a pierceable 
septum cap and wrapped with electrical tape. The reaction vial was placed under high 
vacuum on a Schlenk line for 10 min. Next, with the aid of an argon-filled balloon, the vial was 
placed under an argon atmosphere (running the reaction under an atmosphere of nitrogen can 
lead to lower reproducibility). Then, anhydrous DMA (2.1 mL) was added, and the reaction 
mixture was allowed to stir for 15 min, after which it appeared cloudy and orange (the 
reaction mixture should be orange; if there is contamination by oxygen, the reaction mixture 
may appear nearly colorless). Next, the solution of the alkylzinc bromide (0.60 mmol; the use 
of solutions between 0.70 M and 1.00 M is recommended) was added as a stream over 10–20 
seconds, leading to a dark red-black/brown reaction mixture (if there is contamination by 
oxygen, the reaction mixture may appear bright red). Vacuum grease was then liberally 
applied to cover the punctures in the septum cap, the argon balloon was removed, and 
vacuum grease was applied to cover the puncture. The reaction mixture was then stirred at 
room temperature at ~800 rpm for 20 h. Next, the reaction mixture was directly transferred to a 
column of silica gel for purification without any additional workup. 
 
  
                                                 
(12) Son, S.; Fu, G. C. J. Am. Chem. Soc. 2008, 130, 2756–2757. 
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(1-(1,3-Dioxolan-2-yl)octan-3-yl)(ethyl)diphenylsilane (Table 2, entry 1). The title 
compound was synthesized according to the General Procedure from (1-
bromohexyl)(ethyl)diphenylsilane (188 mg, 0.500 mmol) and (2-(1,3-dioxolan-2-yl)ethyl)zinc 
bromide (0.600 mmol). The product was purified by flash chromatography (0 → 3% EtOAc in 
hexanes). Colorless oil. 
(S,S)–L*: 122 mg (62% yield), +90% ee; (R,R)–L*: 133 mg (67% yield), –91% ee. 
SFC analysis: The ee was determined via SFC on a CHIRALCEL OJ column (5% i-PrOH in 
supercritical CO2, 3.5 mL/min) with tr = 3.2 min (major (S,S)–L*), 3.7 min (major (R,R)–L*). 
1H NMR (400 MHz, CDCl3) δ 7.58–7.47 (m, 4H), 7.42–7.29 (m, 6H), 4.73 (t, J = 4.5 Hz, 1H), 
3.97–3.85 (m, 2H), 3.85–3.75 (m, 2H), 1.79–1.65 (m, 2H), 1.65–1.50 (m, 2H), 1.49–1.38 (m, 1H), 
1.38–1.25 (m, 3H), 1.25–1.13 (m, 5H), 1.13–1.06 (m, 2H), 0.96 (t, J = 7.7 Hz, 3H), 0.82 (t, J = 6.9 Hz, 
3H); 
13C NMR (101 MHz, CDCl3) δ 135.8, 135.70, 135.68, 135.6, 129.22, 129.21, 127.89, 127.88, 
105.0, 65.01, 64.99, 34.1, 32.4, 30.0, 29.5, 24.5, 23.0, 22.8, 14.3, 7.9, 4.5; 
FT‐IR (thin film) 3068, 2953, 2929, 2873, 1456, 1428, 1140, 1109, 1036, 944 cm‐1; 
HR‐MS (FAB+) m/z [M+H]+–H2 calcd for C25H35O2Si: 395.2406, found: 395.2392; 
[α]23D = –0.8 (c = 0.72, CHCl3); +90% ee from (S,S)–L*. 
 
 
 
(4-(1,3-Dioxolan-2-yl)-1-phenylbutan-2-yl)(ethyl)diphenylsilane (Table 2, entry 2). The 
title compound was synthesized according to the General Procedure from (1-bromo-2-
phenylethyl)(ethyl)diphenylsilane (198 mg, 0.500 mmol) and (2-(1,3-dioxolan-2-yl)ethyl)zinc 
bromide (0.600 mmol). The product was purified by flash chromatography (10 → 15% EtOAc 
in hexanes). Colorless waxy solid. 
(S,S)–L*: 136 mg (65% yield), +93% ee; (R,R)–L*: 135 mg (65% yield), –94% ee. 
SFC analysis: The ee was determined via SFC on a CHIRALPAK IC-3 column (2% i-PrOH 
in supercritical CO2, 3.5 mL/min) with tr = 13.6 min (major (S,S)–L*), 16.2 min (major (R,R)–L*). 
1H NMR (400 MHz, CDCl3) δ 7.61 – 7.54 (m, 4H), 7.43 – 7.34 (m, 6H), 7.25 – 7.20 (m, 2H), 
7.17 – 7.12 (m, 3H), 4.59 (t, J = 4.6 Hz, 1H), 3.87 – 3.77 (m, 2H), 3.77 – 3.68 (m, 2H), 2.93 (dd, J = 
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14.1, 3.9 Hz, 1H), 2.46 (dd, J = 14.1, 10.1 Hz, 1H), 1.76 – 1.62 (m, 2H), 1.50 – 1.39 (m, 3H), 1.06 (q, 
J = 7.3 Hz, 2H), 0.93 (t, J = 7.6 Hz, 3H); 
13C NMR (101 MHz, CDCl3) δ 142.7, 135.50, 135.46, 135.0, 134.9, 129.2, 128.78, 128.77, 128.2, 
127.80, 127.79, 125.7, 104.7, 64.7, 64.6, 36.4, 33.6, 25.1, 24.0, 7.6, 4.3; 
FT‐IR (thin film) 3023, 2952, 2874, 1601, 1495, 1493, 1427, 1134, 1108, 1030, 944 cm‐1; 
HR‐MS (FAB+) m/z [M+H]+–H2 calcd for C27H31O2Si: 415.2093, found: 415.2073; 
[α]23D = –1.4 (c = 0.50, CHCl3); +93% ee from (S,S)–L*. 
 
 
 
(1-(1,3-Dioxolan-2-yl)hept-6-en-3-yl)(ethyl)diphenylsilane (Table 2, entry 3). The title 
compound was synthesized according to the General Procedure from (1-bromopent-4-en-1-
yl)(ethyl)diphenylsilane (180 mg, 0.500 mmol) and (2-(1,3-dioxolan-2-yl)ethyl)zinc bromide 
(0.600 mmol). The product was purified by flash chromatography (5% EtOAc in hexanes). 
Colorless oil. 
(S,S)–L*: 100 mg (53% yield), –90% ee; (R,R)–L*: 104 mg (55% yield), +92% ee. 
SFC analysis: The ee was determined via SFC on a CHIRALCEL OJ column (7% i-PrOH in 
supercritical CO2, 3.5 mL/min) with tr = 7.0 min (major (S,S)–L*), 3.5 min (major (R,R)–L*). 
1H NMR (400 MHz, CDCl3) δ 7.58 – 7.48 (m, 4H), 7.42 – 7.31 (m, 6H), 5.71 (ddt, J = 17.0, 10.2, 
6.7 Hz, 1H), 4.98 – 4.86 (m, 2H), 4.74 (t, J = 4.5 Hz, 1H), 3.96 – 3.84 (m, 2H), 3.87 – 3.74 (m, 2H), 
2.16 – 2.04 (m, 1H), 2.03 – 1.92 (m, 1H), 1.79 – 1.63 (m, 3H), 1.62 – 1.53 (m, 1H), 1.51 – 1.37 (m, 
2H), 1.37 – 1.29 (m, 1H), 1.12 (q, J = 7.8 Hz, 2H), 0.96 (t, J = 7.7 Hz, 3H); 
13C NMR (101 MHz, CDCl3) δ 139.0, 135.59, 135.55, 135.4, 135.3, 129.22, 129.20, 127.85, 
127.84, 114.7, 104.9, 64.93, 64.90, 33.9, 33.6, 29.4, 24.1, 22.2, 7.8, 4.3; 
FT‐IR (thin film) 3069, 2952, 2925, 2875, 1427, 1415, 1139, 1108, 1038, 998, 911 cm‐1; 
HR‐MS (ESI+) m/z [M+Na]+ calcd for C24H32NaO2Si: 403.2069, found: 403.2066; 
[α]23D = +4.0 (c = 0.72, CHCl3); –90% ee from (S,S)–L*. 
 
 
 
(1-(1,3-Dioxolan-2-yl)-5-phenylpentan-3-yl)(ethyl)diphenylsilane (Table 2, entry 4). The 
title compound was synthesized according to the General Procedure from (1-bromo-3-
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phenylpropyl)(ethyl)diphenylsilane (205 mg, 0.500 mmol) and (2-(1,3-dioxolan-2-yl)ethyl)zinc 
bromide (0.600 mmol). The product was purified by flash chromatography (0 → 5% EtOAc in 
hexanes). Colorless oil. 
(S,S)–L*: 163 mg (76% yield), –94% ee; (R,R)–L*: 153 mg (71% yield), +92% ee. 
SFC analysis: The ee was determined via SFC on a CHIRALCEL OJ column (35% i‐PrOH in 
supercritical CO2, 3.5 mL/min) with tr = 6.8 min (major (S,S)–L*), 4.4 min (major (R,R)–L*). 
1H NMR (400 MHz, CDCl3) δ 7.57–7.44 (m, 4H), 7.42–7.29 (m, 6H), 7.26–7.20 (m, 2H), 7.16 
(tt, J = 7.3, 1.3 Hz, 1H), 7.05 (d, J = 7.5 Hz, 2H), 4.76 (t, J = 4.6 Hz, 1H), 3.98–3.87 (m, 2H), 3.87–
3.77 (m, 2H), 2.64 (ddd, J = 13.5, 10.6, 5.0 Hz, 1H), 2.48 (ddd, J = 13.5, 10.6, 6.4 Hz, 1H), 1.89 
(dddd, J = 14.0, 10.7, 6.4, 4.4 Hz, 1H), 1.84–1.68 (m, 2H), 1.68–1.47 (m, 3H), 1.37 (tt, J = 7.9, 4.4 
Hz, 1H), 1.17–1.08 (m, 2H), 0.95 (t, J = 7.7 Hz, 3H); 
13C NMR (101 MHz, CDCl3) δ 142.8, 135.7, 135.6, 135.5, 135.3, 129.4, 129.3, 128.7, 128.5, 
127.98, 127.95, 125.9, 104.9, 65.04, 65.01, 35.9, 33.9, 32.2, 24.2, 22.5, 7.9, 4.4; 
FT‐IR (thin film) 3068, 3023, 2950, 2874, 1602, 1495, 1454, 1427, 1133, 1108, 1030, 944 cm‐1; 
HR‐MS (FAB+) m/z [M+H]+–H2 calcd for C28H33O2Si: 429.2250, found: 429.2257; 
[α]23D = +7.5 (c = 0.54, CHCl3); –94% ee from (S,S)–L*. 
 
 
 
(1-(1,3-Dioxolan-2-yl)-5-(4-methoxyphenyl)pentan-3-yl)(ethyl)diphenylsilane (Table 2, 
entry 5). The title compound was synthesized according to the General Procedure from (1-
bromo-3-(4-methoxyphenyl)propyl)(ethyl)diphenylsilane (220 mg, 0.500 mmol) and (2-(1,3-
dioxolan-2-yl)ethyl)zinc bromide (0.600 mmol). The product was purified by flash 
chromatography (0 → 5% EtOAc in hexanes). Colorless oil. 
(S,S)–L*: 199 mg (86% yield), –90% ee; (R,R)–L*: 199 mg (86% yield), +93% ee. 
SFC analysis: The ee was determined via SFC on a CHIRALCEL OJ column (40% i-PrOH in 
supercritical CO2, 3.5 mL/min) with tr = 8.1 min (major (S,S)–L*), 4.5 min (major (R,R)–L*). 
1H NMR (400 MHz, CDCl3) δ 7.57–7.45 (m, 4H), 7.42–7.30 (m, 6H), 6.97 (d, J = 8.4 Hz, 2H), 
6.79 (d, J = 8.4 Hz, 2H), 4.76 (t, J = 4.6 Hz, 1H), 3.97–3.87 (m, 2H), 3.87–3.79 (m, 2H), 3.78 (s, 3H), 
2.59 (ddd, J = 13.7, 10.5, 5.0 Hz, 1H), 2.44 (ddd, J = 13.7, 10.5, 6.4 Hz, 1H), 1.92–1.68 (m, 3H), 
1.66–1.49 (m, 3H), 1.36 (ddd, J = 11.8, 7.6, 4.3 Hz, 1H), 1.17–1.08 (m, 2H), 0.96 (t, J = 7.7 Hz, 3H); 
13C NMR (101 MHz, CDCl3) δ 157.8, 135.7, 135.6, 135.5, 135.4, 134.9, 129.6, 129.33, 129.29, 
128.0, 127.9, 113.9, 104.9, 65.04, 65.01, 55.5, 34.9, 33.9, 32.4, 24.2, 22.4, 7.9, 4.4; 
FT‐IR (thin film) 3068, 2951, 2875, 1611, 1512, 1458, 1300, 1246, 1177, 1133, 1109, 1037, 945, 
821 cm‐1; 
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HR‐MS (FAB+) m/z [M+H]+–H2 calcd for C29H35O3Si: 459.2356, found: 459.2345; 
[α]23D = +11.9 (c = 0.52, CHCl3); –90% ee from (S,S)–L*. 
 
 
 
(1-(4-Chlorophenyl)-5-(1,3-dioxolan-2-yl)pentan-3-yl)(ethyl)diphenylsilane (Table 2, 
entry 6). The title compound was synthesized according to the General Procedure from (1-
bromo-3-(4-chlorophenyl)propyl)(ethyl)diphenylsilane (222 mg, 0.500 mmol) and (2-(1,3-
dioxolan-2-yl)ethyl)zinc bromide (0.600 mmol). The product was purified by flash 
chromatography (0 → 5% EtOAc in hexanes). Colorless oil. 
(S,S)–L*: 116 mg (50% yield), –90% ee; (R,R)–L*: 140 mg (60% yield), +92% ee. 
SFC analysis: The ee was determined via SFC on a CHIRALCEL OJ column (35% i-PrOH in 
supercritical CO2, 3.5 mL/min) with tr = 10.7 min (major (S,S)–L*), 4.8 min (major (R,R)–L*). 
1H NMR (400 MHz, CDCl3) δ 7.56–7.44 (m, 4H), 7.43–7.29 (m, 6H), 7.20 (d, J = 8.3 Hz, 2H), 
6.95 (d, J = 8.3 Hz, 2H), 4.76 (t, J = 4.6 Hz, 1H), 3.98–3.87 (m, 2H), 3.87–3.77 (m, 2H), 2.60 (ddd, J 
= 13.7, 10.3, 5.1 Hz, 1H), 2.45 (ddd, J = 13.7, 10.3, 6.6 Hz, 1H), 1.92–1.67 (m, 3H), 1.66–1.46 (m, 
3H), 1.34 (ddt, J = 8.7, 7.6, 4.5 Hz, 1H), 1.16–1.08 (m, 2H), 0.96 (t, J = 7.8 Hz, 3H); 
13C NMR (101 MHz, CDCl3) δ 141.2, 135.7, 135.6, 135.4, 135.2, 131.5, 130.0, 129.42, 129.38, 
128.5, 128.02, 128.00, 104.8, 65.1, 65.0, 35.1, 33.9, 32.2, 24.2, 22.4, 7.9, 4.4; 
FT‐IR (thin film) 3068, 2950, 2874, 1491, 1427, 1134, 1108, 1037, 1014, 808 cm‐1; 
HR‐MS (FAB+) m/z [M+H]+–H2 calcd for C28H32ClO2Si: 463.1860, found: 463.1869; 
[α]23D = +14.8 (c = 0.47, CHCl3); –90% ee from (S,S)–L*. 
 
 
 
(1-Cyclohexyl-4-(1,3-dioxolan-2-yl)butan-2-yl)(ethyl)diphenylsilane (Table 2, entry 7). 
The title compound was synthesized according to the General Procedure from (1-bromo-2-
cyclohexylethyl)(ethyl)diphenylsilane (201 mg, 0.500 mmol) and (2-(1,3-dioxolan-2-
yl)ethyl)zinc bromide (0.600 mmol). The product was purified by flash chromatography (0 → 
3% EtOAc in hexanes). Colorless oil. 
(S,S)–L*: 132 mg (62% yield), +90% ee; (R,R)–L*: 119 mg (56% yield), –91% ee. 
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SFC analysis: The ee was determined via SFC on a CHIRALCEL OJ column (5% i-PrOH in 
supercritical CO2, 3.5 mL/min) with tr = 4.7 min (major (S,S)–L*), 5.6 min (major (R,R)–L*). 
1H NMR (400 MHz, CDCl3) δ 7.58–7.49 (m, 4H), 7.42–7.31 (m, 6H), 4.71 (t, J = 4.6 Hz, 1H), 
3.95–3.85 (m, 2H), 3.85–3.75 (m, 2H), 1.78 (d, J = 13.0 Hz, 1H), 1.74–1.53 (m, 7H), 1.48–1.32 (m, 
3H), 1.30–1.07 (m, 7H), 0.96 (t, J = 7.7 Hz, 3H), 0.88–0.64 (m, 2H); 
13C NMR (101 MHz, CDCl3) δ 135.74, 135.67, 135.66, 135.6, 129.22, 129.19, 127.88, 127.86, 
105.0, 65.0 (two carbons), 38.2, 36.4, 34.6, 34.0, 32.9, 26.9, 26.65, 26.57, 24.9, 19.3, 7.9, 4.4; 
FT‐IR (thin film) 3068, 2922, 2851, 1448, 1428, 1260, 1229, 1131, 1108, 1033, 945 cm‐1; 
HR‐MS (FAB+) m/z [M+H]+–H2 calcd for C27H37O2Si: 421.2563, found: 421.2576; 
[α]23D = –4.1 (c = 0.48, CHCl3); +90% ee from (S,S)–L*. 
 
 
 
(4-(1,3-Dioxolan-2-yl)-1-(tetrahydro-2H-pyran-4-yl)butan-2-yl)(ethyl)diphenylsilane 
(Table 2, entry 8). The title compound was synthesized according to the General Procedure 
from (1-bromo-2-(tetrahydro-2H-pyran-4-yl)ethyl)(ethyl)diphenylsilane (202 mg, 0.500 mmol) 
and (2-(1,3-dioxolan-2-yl)ethyl)zinc bromide (0.600 mmol). The product was purified by flash 
chromatography (5 → 15% EtOAc in hexanes). Colorless oil. 
(S,S)–L*: 136 mg (64% yield), –91% ee; (R,R)–L*: 150 mg (71% yield), +92% ee. 
SFC analysis: The ee was determined via SFC on a CHIRALCEL OJ column (10% i-PrOH in 
supercritical CO2, 3.5 mL/min) with tr = 23.6 min (major (S,S)–L*), 3.4 min (major (R,R)–L*). 
1H NMR (400 MHz, CDCl3) δ 7.57–7.47 (m, 4H), 7.42–7.30 (m, 6H), 4.71 (t, J = 4.6 Hz, 1H), 
3.96–3.74 (m, 6H), 3.25 (tdd, J = 11.4, 9.3, 2.2 Hz, 2H), 1.78–1.52 (m, 4H), 1.51–1.36 (m, 5H), 1.30–
1.15 (m, 2H), 1.14–1.03 (m, 3H), 0.95 (t, J = 7.7 Hz, 3H); 
13C NMR (101 MHz CDCl3) δ 135.7, 135.6, 135.4, 135.2, 129.39, 129.36, 127.98, 127.97, 104.9, 
68.33, 68.30, 65.024, 65.016, 37.7, 34.2, 34.0, 33.8, 32.8, 24.8, 19.0, 7.9, 4.3; 
FT‐IR (thin film) 3069, 2928, 2876, 1427, 1236, 1131, 1108, 1091, 1015, 982 cm‐1; 
HR‐MS (FAB+) m/z [M+H]+ calcd for C26H37O3Si: 425.2512, found: 425.2527; 
[α]23D = –4.8 (c = 0.52, CHCl3); –91% ee from (S,S)–L*. 
 
 
  
 S–25 
 
Tert-butyl 4-(4-(1,3-dioxolan-2-yl)-2-(ethyldiphenylsilyl)butyl)piperidine-1-carboxylate 
(Table 2, entry 9). The title compound was synthesized according to the General Procedure 
from tert-butyl 4-(2-bromo-2-(ethyldiphenylsilyl)ethyl)piperidine-1-carboxylate (251 mg, 
0.500 mmol) and (2-(1,3-dioxolan-2-yl)ethyl)zinc bromide (0.600 mmol). The product was 
purified by flash chromatography (5 → 15% EtOAc in hexanes). Colorless oil. 
(S,S)–L*: 178 mg (68% yield), –90% ee; (R,R)–L*: 180 mg (69% yield), +90% ee. 
SFC analysis: The ee was determined via SFC on a CHIRALPAK AD-H column (10% i-
PrOH in supercritical CO2, 3.5 mL/min) with tr = 4.6 min (major (S,S)–L*), 3.9 min (major (R,R)–
L*). 
1H NMR (500 MHz, d6-DMSO, 75 °C) δ 6.98 – 6.88 (m, 4H), 6.85 – 6.75 (m, 6H), 4.16 – 3.96 
(m, 1H), 3.23 – 3.07 (m, 4H), 2.02 – 1.88 (m, 4H), 1.10 – 1.01 (m, 2H), 1.00 – 0.74 (m, 16H), 0.69 – 
0.59 (m, 1H), 0.53 (q, J = 8.0, 2.5 Hz, 2H), 0.37 (t, J = 7.6 Hz, 3H), 0.32 – 0.13 (m, 2H); 
13C NMR (126 MHz, d6-DMSO, 75 °C) δ 154.5, 135.7, 135.63, 135.56, 135.5, 129.68, 129.66, 
128.34, 128.33, 104.4, 79.0, 64.75, 64.72, 44.2 (br; two carbons), 37.5, 34.9, 33.9, 33.1, 32.0, 28.8, 
25.2, 19.8, 8.1, 4.0; 
FT‐IR (thin film) 3069, 2929, 2875, 1693, 1427, 1365, 1281, 1241, 1169, 1109, 1033, 947 cm‐1; 
HR‐MS (FAB+) m/z [M+H]+–H2 calcd for C31H44NO4Si: 522.3040, found: 522.3051; 
[α]23D = +8.2 (c = 0.56, CHCl3); –90% ee from (S,S)–L*. 
 
 
 
(1-(1,3-Dioxolan-2-yl)-5-(5-methylfuran-2-yl)pentan-3-yl)(ethyl)diphenylsilane (Table 2, 
entry 10). The title compound was synthesized according to the General Procedure from (1-
bromo-3-(5-methylfuran-2-yl)propyl)(ethyl)diphenylsilane (207 mg, 0.500 mmol) and (2-(1,3-
dioxolan-2-yl)ethyl)zinc bromide (0.600 mmol). The product was purified by flash 
chromatography (0 → 5% EtOAc in hexanes). Pale-yellow oil. 
(S,S)–L*: 152 mg (70% yield), –89% ee; (R,R)–L*: 158 mg (73% yield), +91% ee. 
SFC analysis: The ee was determined via SFC on a CHIRALCEL OJ column (15% i-PrOH in 
supercritical CO2, 3.5 mL/min) with tr = 11.6 min (major (S,S)–L*), 8.1 min (major (R,R)–L*). 
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1H NMR (400 MHz, CDCl3) δ 7.54–7.45 (m, 4H), 7.41–7.30 (m, 6H), 5.82 (dd, J = 3.0, 1.0 Hz, 
1H), 5.76 (d, J = 3.0 Hz, 1H), 4.73 (t, J = 4.6 Hz, 1H), 3.95–3.85 (m, 2H), 3.85–3.75 (m, 2H), 2.60 
(ddd, J = 14.7, 9.3, 5.4 Hz, 1H), 2.50 (ddd, J = 15.8, 8.7, 7.2 Hz, 1H), 2.24 (d, J = 0.6 Hz, 3H), 1.93 
(dddd, J = 13.8, 9.3, 7.0, 4.3 Hz, 1H), 1.80–1.56 (m, 4H), 1.52–1.40 (m, 1H), 1.34 (ddt, J = 8.4, 7.2, 
4.3 Hz, 1H), 1.11 (q, J = 7.8 Hz, 2H), 0.94 (t, J = 7.8 Hz, 3H); 
13C NMR (101 MHz, CDCl3) δ 154.4, 150.4, 135.7, 135.6, 135.4, 135.3, 129.4, 129.3, 127.97, 
125.95, 105.9, 105.8, 104.9, 65.03, 65.00, 33.9, 28.6, 27.8, 24.1, 21.9, 13.8, 7.9, 4.4; 
FT‐IR (thin film) 3068, 2951, 2875, 1568, 1427, 1218, 1134, 1108, 1021, 943 cm‐1; 
HR‐MS (FAB+) m/z [M+H]+–H2 calcd for C27H33O3Si: 433.2199, found: 433.2181; 
[α]23D = –3.8 (c = 0.58, CHCl3); –89% ee from (S,S)–L*. 
 
 
 
(1-(1,3-Dioxolan-2-yl)-5-phenylpentan-3-yl)(methyl)diphenylsilane (Table 2, entry 11). 
The title compound was synthesized according to the General Procedure from (1-bromo-3-
phenylpropyl)(methyl)diphenylsilane (198 mg, 0.500 mmol) and (2-(1,3-dioxolan-2-
yl)ethyl)zinc bromide (0.600 mmol). The product was purified by flash chromatography (0 → 
7% EtOAc in hexanes). Colorless oil. 
(S,S)–L*: 163 mg (78% yield), –86% ee; (R,R)–L*: 170 mg (82% yield), +84% ee. 
HPLC analysis: The ee was determined via SFC on a CHIRALCEL OJ column (15% i-PrOH 
in hexane, 3.5 mL/min) with tr = 8.7 min (major (S,S)–L*), 4.4 min (major (R,R)–L*). 
1H NMR (400 MHz, CDCl3) δ 7.58 – 7.47 (m, 4H), 7.43 – 7.30 (m, 6H), 7.26 – 7.21 (m, 2H), 
7.20 – 7.13 (m, 1H), 7.07 – 6.98 (m, 2H), 4.76 (t, J = 4.3 Hz, 1H), 4.00 – 3.87 (m, 2H), 3.86 – 3.75 
(m, 2H), 2.64 (ddd, J = 13.4, 10.5, 5.2 Hz, 1H), 2.47 (ddd, J = 13.4, 10.5, 6.3 Hz, 1H), 1.95 – 1.57 
(m, 6H), 1.35 (tt, J = 7.2, 4.7 Hz, 1H), 0.61 (s, 3H); 
13C NMR (101 MHz, CDCl3) δ 142.8, 137.0, 136.8, 135.02, 134.95, 129.35, 129.32, 128.7, 128.4, 
128.03, 128.02, 125.9, 104.9, 65.01, 64.99, 35.7, 33.7, 32.2, 24.2, 23.4, –5.1; 
FT‐IR (thin film) 3067, 3023, 2924, 2858, 1602, 1495, 1454, 1427, 1252, 1133, 1110, 1038, 944, 
873 cm‐1; 
HR‐MS (ESI+) m/z [M+H]+–H2 calcd for C27H31O2Si: 415.2093, found: 415.2083; 
[α]23D = –5.3 (c = 0.53, CHCl3); –86% ee from (S,S)–L*. 
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(1-(1,3-Dioxolan-2-yl)-5-phenylpentan-3-yl)trimethylsilane (Table 2, entry 12). The title 
compound was synthesized according to the General Procedure from (1-bromo-3-
phenylpropyl)trimethylsilane (137 mg, 0.500 mmol) and (2-(1,3-dioxolan-2-yl)ethyl)zinc 
bromide (0.600 mmol). The product was purified by flash chromatography (0 → 2% EtOAc in 
hexanes). Colorless oil. 
(S,S)–L*: 114 mg (78% yield), +86% ee; (R,R)–L*: 121 mg (83% yield), –84% ee. 
SFC analysis: The ee was determined via SFC on a CHIRALPAK AD-H column (2% i-PrOH 
in supercritical CO2, 3.5 mL/min) with tr = 2.5 min (major (S,S)–L*), 2.8 min (major (R,R)–L*). 
1H NMR (400 MHz, CDCl3) δ 7.33 – 7.25 (m, 2H), 7.21 – 7.15 (m, 3H), 4.84 (t, J = 4.7 Hz, 1H), 
4.03 – 3.94 (m, 2H), 3.92 – 3.81 (m, 2H), 2.70 (ddd, J = 13.5, 10.9, 5.3 Hz, 1H), 2.56 (ddd, J = 13.5, 
10.9, 6.0 Hz, 1H), 1.82 – 1.45 (m, 6H), 0.67 (tt, J = 7.4, 5.1 Hz, 1H), 0.03 (s, 9H); 
13C NMR (101 MHz, CDCl3) δ 143.2, 128.6, 128.5, 125.9, 105.1, 65.08, 65.06, 35.7, 33.5, 32.0, 
25.5, 24.0, –1.9; 
FT‐IR (thin film) 3026, 2950, 2859, 1603, 1496, 1454, 1407, 1248, 1135, 1092, 1040, 944, 855, 
834 cm‐1; 
HR‐MS (ESI+) m/z [M+H]+–H2 calcd for C17H27O2Si: 291.1780, found: 291.1782; 
[α]23D = –6.7 (c = 0.68, CHCl3); +86% ee from (S,S)–L*. 
 
 
 
(1-(1,3-Dioxolan-2-yl)-5-phenylpentan-3-yl)triethylsilane (Table 2, entry 13). The title 
compound was synthesized according to the General Procedure from (1-bromo-3-
phenylpropyl)triethylsilane (157 mg, 0.500 mmol) and (2-(1,3-dioxolan-2-yl)ethyl)zinc bromide 
(0.600 mmol). The product was purified by flash chromatography (0 → 5% EtOAc in hexanes). 
Colorless oil. 
(S,S)–L*: 77 mg (46% yield), +92% ee; (R,R)–L*: 92 mg (55% yield), –89% ee. 
SFC analysis: The ee was determined via SFC on a CHIRALCEL OJ column (1% i-PrOH in 
supercritical CO2, 3.5 mL/min) with tr = 6.1 min (major (S,S)–L*), 7.3 min (major (R,R)–L*). 
1H NMR (400 MHz, CDCl3) δ 7.31 – 7.23 (m, 2H), 7.21 – 7.12 (m, 3H), 4.83 (t, J = 4.7 Hz, 1H), 
4.07 – 3.92 (m, 2H), 3.91 – 3.79 (m, 2H), 2.71 (ddd, J = 13.4, 11.0, 5.1 Hz, 1H), 2.54 (ddd, J = 13.4, 
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10.9, 5.9 Hz, 1H), 1.84 – 1.44 (m, 6H), 0.94 (t, J = 7.9 Hz, 9H), 0.80 – 0.76 (m, 1H), 0.58 (q, J = 8.1 
Hz, 6H); 
13C NMR (101 MHz, CDCl3) δ 143.2, 128.6, 128.5, 125.9, 105.1, 65.11, 65.08, 36.1, 34.0, 32.3, 
24.2, 22.7, 8.0, 3.1; 
FT‐IR (thin film) 3026, 2951, 2910, 2874, 1496, 1454, 1413, 1238, 1137, 1092, 1040, 1016, 944, 
872 cm‐1; 
HR‐MS (ESI+) m/z [M+H]+–H2 calcd for C20H33O2Si: 333.2250, found: 333.2250; 
[α]23D = –7.0 (c = 0.49, CHCl3); +92% ee from (S,S)–L*. 
 
 
 
(1-(1,3-Dioxolan-2-yl)-5-phenylpentan-3-yl)(tert-butyl)dimethylsilane (Table 2, entry 14). 
The title compound was synthesized according to the General Procedure from (1-bromo-3-
phenylpropyl)(tert-butyl)dimethylsilane (157 mg, 0.500 mmol) and (2-(1,3-dioxolan-2-
yl)ethyl)zinc bromide (0.600 mmol). The product was purified by flash chromatography (0 → 
2% EtOAc in hexanes). Colorless oil. 
(S,S)–L*: 46 mg (27% yield), +84% ee; (R,R)–L*: 39 mg (23% yield), –85% ee. 
SFC analysis: The ee was determined via SFC on a CHIRALCEL OJ column (1% i-PrOH in 
supercritical CO2, 3.5 mL/min) with tr = 3.4 min (major (S,S)–L*), 3.8 min (major (R,R)–L*). 
1H NMR (400 MHz, CDCl3) δ 7.31 – 7.24 (m, 2H), 7.22 – 7.15 (m, 3H), 4.84 (t, J = 4.4 Hz, 1H), 
4.04 – 3.94 (m, 2H), 3.92 – 3.80 (m, 2H), 2.71 (ddd, J = 13.4, 11.1, 5.0 Hz, 1H), 2.54 (ddd, J = 13.5, 
11.0, 5.9 Hz, 1H), 1.89 – 1.47 (m, 6H), 0.89 (s, 9H), 0.87 – 0.81 (m, 1H), –0.01 (s, 6H); 
13C NMR (101 MHz, CDCl3) δ 143.1, 128.6, 128.5, 125.9, 105.1, 65.11, 65.08, 35.6, 33.4, 32.4, 
27.5, 24.2, 22.4, 17.7, –6.0; 
FT‐IR (thin film) 3026, 2953, 2928, 2856, 1496, 1471, 1409, 1362, 1250, 1138, 1040, 941, 837, 
806 cm‐1; 
HR‐MS (ESI+) m/z [M+H]+–H2 calcd for C20H33O2Si: 333.2250, found: 333.2235; 
[α]23D = –5.5 (c = 0.74, CHCl3); +84% ee from (S,S)–L*. 
 
 
 
Ethyl(8-fluoro-1-phenyloctan-3-yl)diphenylsilane (Table 3, entry 1). The title compound 
was synthesized according to the General Procedure from (1-bromo-3-
phenylpropyl)(ethyl)diphenylsilane (205 mg, 0.500 mmol) and (5-fluoropentyl)zinc bromide 
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(0.600 mmol). The product was purified by flash chromatography (0 → 25% CH2Cl2 in 
hexanes). Colorless oil. 
(S,S)–L*: 125 mg (58% yield), –87% ee; (R,R)–L*: 118 mg (55% yield), +87% ee. 
SFC analysis: The ee was determined via SFC on a CHIRALCEL OJ column (20% i-PrOH in 
supercritical CO2, 3.5 mL/min) with tr = 6.8 min (major (S,S)–L*), 5.5 min (major (R,R)–L*). 
1H NMR (400 MHz, CDCl3) δ 7.55 – 7.46 (m, 4H), 7.43 – 7.31 (m, 6H), 7.28 – 7.22 (m, 2H), 
7.20 – 7.14 (m, 1H), 7.09 – 7.02 (m, 2H), 4.38 (dt, J = 47.3, 6.2 Hz, 2H), 2.64 (ddd, J = 13.4, 10.6, 5.2 
Hz, 1H), 2.50 (ddd, J = 13.4, 10.4, 6.3 Hz, 1H), 1.90 (dddd, J = 13.8, 10.6, 6.3, 4.3 Hz, 1H), 1.71 – 
1.56 (m, 4H), 1.47 – 1.22 (m, 6H), 1.12 (q, J = 7.8 Hz, 2H), 0.97 (t, J = 7.7 Hz, 3H); 
13C NMR (101 MHz, CDCl3) δ 142.7, 135.45, 135.42, 135.40, 134.9, 129.09, 129.07, 128.5, 128.3, 
127.74, 127.72, 125.7, 84.2 (d, J = 164.1 Hz), 35.9, 32.2, 30.3 (d, J = 19.4 Hz), 29.8, 29.1, 25.5 (d, J = 
5.5 Hz), 22.4, 7.7, 4.3; 
FT‐IR (thin film) 3024, 2932, 2857, 1455, 1428, 1108, 1010 cm‐1; 
HR‐MS (ESI+) m/z [M+Na]+ calcd for C28H35FNaSi: 441.2390, found: 441.2390; 
[α]23D = +8.1 (c = 0.70, CHCl3); –87% ee from (S,S)–L*. 
 
 
 
Ethyl(6-phenoxy-1-phenylhexan-3-yl)diphenylsilane (Table 3, entry 2). The title 
compound was synthesized according to the General Procedure from (1-bromo-3-
phenylpropyl)(ethyl)diphenylsilane (205 mg, 0.500 mmol) and (3-phenoxypropyl)zinc bromide 
(0.600 mmol). The product was purified by flash chromatography with silica gel: column #1 (0 
→ 2% EtOAc in hexanes); column #2 (20 → 40% CH2Cl2 in hexanes). Colorless oil. 
(S,S)–L*: 193 mg (83% yield), +87% ee; (R,R)–L*: 182 mg (78% yield), –89% ee. 
SFC analysis: The ee was determined via SFC on a CHIRALCEL OD-H column (30% i-
PrOH in supercritical CO2, 3.5 mL/min) with tr = 3.0 min (major (S,S)–L*), 3.8 min (major (R,R)–
L*). 
1H NMR (400 MHz, CDCl3) δ 7.59–7.47 (m, 4H), 7.44–7.32 (m, 6H), 7.31–7.22 (m, 4H), 7.17 
(tt, J = 7.3, 1.3 Hz, 1H), 7.10–7.03 (m, 2H), 6.94 (tt, J = 7.3, 1.0 Hz, 1H), 6.90–6.83 (m, 2H), 3.94–
3.81 (m, 2H), 2.66 (ddd, J = 13.6, 10.6, 5.2 Hz, 1H), 2.52 (ddd, J = 13.6, 10.4, 6.4 Hz, 1H), 2.00–1.49 
(m, 6H), 1.41 (tt, J = 7.7, 4.4 Hz, 1H), 1.20–1.10 (m, 2H), 0.97 (t, J = 7.8 Hz, 3H); 
13C NMR (101 MHz, CDCl3) δ 159.2, 142.8, 135.7, 135.6, 135.5, 135.4, 129.6, 129.4, 129.3, 128.7, 
128.5, 128.00, 127.98, 125.9, 120.7, 114.7, 67.9, 35.9, 32.3, 29.2, 26.3, 22.3, 7.9, 4.4; 
FT‐IR (thin film) 3067, 3024, 2930, 2873, 1600, 1586, 1496, 1469, 1427, 1301, 1244, 1172, 1108, 
1080, 1030 cm‐1; 
HR‐MS (FAB+) m/z [M+H]+–H2 calcd for C32H35OSi: 463.2457, found: 463.2457; 
[α]23D = –0.6 (c = 0.60, CHCl3); +87% ee from (S,S)–L*. 
Gram-Scale Reaction. An oven-dried 1020-mL vial was charged with(1-bromo-3-
phenylpropyl)(ethyl)diphenylsilane (1.64 g, 4.00 mmol), followed by NiBr2diglyme (123 mg, 
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0.400 mmol) and then (S,S)–L* (171 mg, 0.520 mmol). Next, an oven-dried stir bar was added, 
and the reaction vial was capped with a pierceable septum cap and wrapped with electrical 
tape. The reaction vial was placed under high vacuum on a Schlenk line for 10 min. Next, with 
the aid of an argon-filled balloon, the vial was placed under an argon atmosphere. Then, 
anhydrous DMA (8.8 mL; on a gram-scale, the reaction was conducted at a higher 
concentration) was added, and the reaction mixture was allowed to stir for 15 min, after which 
it appeared cloudy and orange. Next, (3-phenoxypropyl)zinc bromide (4.80 mmol) was added 
as a stream over 10–20 seconds, leading to a dark red-black/brown reaction mixture. Vacuum 
grease was then liberally applied to cover the punctures in the septum cap, the argon balloon 
was removed, and vacuum grease was applied to cover the puncture. The reaction mixture 
was then stirred at room temperature at ~800 rpm for 20 h. Next, the reaction mixture was 
directly transferred to a column of silica gel for purification without any additional workup. 
The reaction mixture was then purified by flash chromatography with silica gel: column #1 (0 
→ 2% EtOAc in hexanes); column #2 (20 → 40% CH2Cl2 in hexanes), which provided 1.66 g 
(89% yield) of a colorless oil (+88% ee). 
 
 
 
Tert-butyl((4-(ethyldiphenylsilyl)-6-phenylhexyl)oxy)dimethylsilane (Table 3, entry 3). 
The title compound was synthesized according to the General Procedure from (1-bromo-3-
phenylpropyl)(ethyl)diphenylsilane (205 mg, 0.500 mmol) and (3-((tert-
butyldimethylsilyl)oxy)propyl)zinc bromide (0.600 mmol). The product was purified by flash 
chromatography (0 → 20% CH2Cl2 in hexanes). Colorless oil. 
(S,S)–L*: 164 mg (65% yield), –87% ee; (R,R)–L*: 182 mg (73% yield), +88% ee. 
SFC analysis: The ee was determined via SFC on a CHIRALCEL OJ column (10% i-PrOH in 
supercritical CO2, 3.5 mL/min) with tr = 3.4 min (major (S,S)–L*), 2.3 min (major (R,R)–L*). 
1H NMR (400 MHz, CDCl3) δ 7.57–7.45 (m, 4H), 7.41–7.30 (m, 6H), 7.27–7.21 (m, 2H), 7.20–
7.13 (m, 1H), 7.08–7.02 (m, 2H), 3.54 (t, J = 6.0 Hz, 2H), 2.64 (ddd, J = 13.3, 10.8, 5.1 Hz, 1H), 2.49 
(13.3, 10.5, 6.4 Hz, 1H), 1.89 (dddd, J = 14.0, 10.7, 6.4, 4.3 Hz, 1H), 1.76–1.56 (m, 3H), 1.53–1.39 
(m, 2H), 1.39–1.31 (m, 1H), 1.12 (q, J = 7.8 Hz, 2H), 0.96 (t, J = 7.8 Hz, 3H), 0.88 (s, 9H), 0.02 (s, 
6H); 
13C NMR (101 MHz, CDCl3) δ 143.0, 135.70, 135.68, 135.64, 135.60, 129.3, 129.2, 128.7, 128.5, 
127.94, 127.93, 125.8, 63.6, 36.0, 33.0, 32.4, 26.23, 26.22, 22.5, 18.6, 7.9, 4.5, –5.00, –5.02; 
FT‐IR (thin film) 3068, 3025, 2953, 2929, 2856, 1462, 1427, 1386, 1255, 1107, 1008, 953, 836  
cm‐1; 
HR‐MS (ESI+) m/z [M+Na]+ calcd for C32H46NaOSi2: 525.2985, found: 525.2969; 
[α]23D = +7.2 (c = 0.76, CHCl3); –87% ee from (S,S)–L*. 
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5-(Ethyldiphenylsilyl)-7-phenylheptanenitrile (Table 3, entry 4). The title compound was 
synthesized according to the General Procedure from (1-bromo-3-
phenylpropyl)(ethyl)diphenylsilane (205 mg, 0.500 mmol) and (3-cyanopropyl)zinc bromide 
(0.600 mmol). The product was purified by flash chromatography (3 → 5% EtOAc in hexanes. 
Colorless oil. 
(S,S)–L*: 108 mg (54% yield), +88% ee; (R,R)–L*: 93 mg (47% yield), –86% ee. 
SFC analysis: The ee was determined via SFC on a CHIRALCEL OJ column (45% MeOH in 
supercritical CO2, 3.5 mL/min) with tr = 7.2 min (major (S,S)–L*), 19.7 min (major (R,R)–L*). 
1H NMR (400 MHz, CDCl3) δ 7.58–7.45 (m, 4H), 7.45–7.31 (m, 6H), 7.29–7.23 (m, 2H), 7.22–
7.14 (m, 1H), 7.11–7.02 (m, 2H), 2.63 (ddd, J = 13.7, 10.1, 5.4 Hz, 1H), 2.51 (ddd, J = 13.7, 10.1, 6.6 
Hz, 1H), 2.28–2.12 (m, 2H), 1.93 (dddd, J = 14.2, 10.6, 6.6, 4.4 Hz, 1H), 1.80–1.71 (m, 1H), 1.70–
1.58 (m, 2H), 1.58–1.47 (m, 2H), 1.38–1.28 (m, 1H), 1.13 (q, J = 7.8 Hz, 2H), 0.97 (t, J = 7.7 Hz, 
3H); 
13C NMR (101 MHz, CDCl3) δ 142.4, 135.56, 135.53, 134.95, 134.93, 129.57, 129.55, 128.7, 
128.6, 128.14, 128.11, 126.1, 119.9, 35.8, 32.0, 29.5, 25.4, 22.3, 17.6, 7.9, 4.3; 
FT‐IR (thin film) 3067, 3024, 2931, 2873, 2244, 1454, 1427, 1108, 1010 cm‐1; 
HR‐MS (FAB+) m/z [M+H]+–H2 calcd for C27H30NSi: 396.2148, found: 396.2142; 
[α]23D = +10.6 (c = 0.48, CHCl3); +88% ee from (S,S)–L*. 
 
 
 
Ethyl 7-(ethyldiphenylsilyl)-9-phenylnonanoate (Table 3, entry 5). The title compound 
was synthesized according to the General Procedure from (1-bromo-3-
phenylpropyl)(ethyl)diphenylsilane (205 mg, 0.500 mmol) and (6-ethoxy-6-oxohexyl)zinc 
bromide (0.600 mmol). The product was purified by flash chromatography with silica gel: 
column #1 (0 → 5% EtOAc in hexanes); column #2 (30 → 60% CH2Cl2 in hexanes). Colorless oil. 
(S,S)–L*: 142 mg (60% yield), –88% ee; (R,R)–L*: 136 mg (58% yield), +86% ee. 
SFC analysis: The ee was determined via SFC on a CHIRALCEL OJ column (20% i-PrOH in 
supercritical CO2, 3.5 mL/min) with tr = 13.9 min (major (S,S)–L*), 9.5 min (major (R,R)–L*). 
1H NMR (400 MHz, CDCl3) δ 7.54 – 7.46 (m, 4H), 7.41 – 7.30 (m, 6H), 7.27 – 7.22 (m, 2H), 
7.20 – 7.13 (m, 1H), 7.08 – 7.03 (m, 2H), 4.12 (q, J = 7.1 Hz, 2H), 2.62 (ddd, J = 13.4, 10.6, 5.1 Hz, 
1H), 2.48 (ddd, J = 13.5, 10.4, 6.3 Hz, 1H), 2.23 (t, J = 7.6 Hz, 2H), 1.88 (dddd, J = 13.7, 10.5, 6.3, 
4.2 Hz, 1H), 1.67 – 1.51 (m, 4H), 1.44 – 1.19 (m, 9H), 1.11 (q, J = 7.4 Hz, 2H), 0.95 (t, J = 7.7 Hz, 
3H); 
13C NMR (101 MHz, CDCl3) δ 174.0, 142.8, 135.6, 135.54, 135.52, 129.19, 129.16, 128.6, 128.4, 
127.84, 127.82, 125.8, 60.3, 36.0, 34.5, 32.3, 29.9, 29.6, 29.3, 25.0, 22.6, 14.4, 7.8, 4.4; 
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FT‐IR (thin film) 3068, 3024, 2930, 2856, 1735, 1454, 1427, 1373, 1180, 1108, 1030 cm‐1; 
HR‐MS (FAB+) m/z [M+H]+–H2 calcd for C31H39O2Si: 471.2719, found: 471.2732; 
[α]23D = +4.5 (c = 0.52, CHCl3); –88% ee from (S,S)–L*. 
 
 
 
Ethyl(6-methyl-1-phenylheptan-3-yl)diphenylsilane (Table 3, entry 6). The title 
compound was synthesized according to the General Procedure from (1-bromo-3-
phenylpropyl)(ethyl)diphenylsilane (205 mg, 0.500 mmol) and isopentylzinc bromide (0.600 
mmol). The product was purified by flash chromatography (0 → 5% CH2Cl2 in hexanes). 
Colorless oil. 
(S,S)–L*: 129 mg (65% yield), +91% ee; (R,R)–L*: 132 mg (66% yield), –91% ee. 
SFC analysis: The ee was determined via SFC on a CHIRALCEL OJ column (15% i-PrOH in 
supercritical CO2, 3.5 mL/min) with tr = 3.5 min (major (S,S)–L*), 5.1 min (major (R,R)–L*). 
1H NMR (400 MHz, CDCl3) δ 7.56–7.45 (m, 4H), 7.41–7.30 (m, 6H), 7.27–7.21 (m, 2H), 7.16 
(tt, J = 7.3, 1.3 Hz, 1H), 7.09–7.03 (m, 2H), 2.63 (ddd, J = 13.5, 10.7, 5.0 Hz, 1H), 2.48 (ddd, J = 
13.5, 10.5, 6.3 Hz, 1H), 1.88 (dddd, J = 14.0, 10.6, 6.4, 4.3 Hz, 1H), 1.71–1.56 (m, 2H), 1.50–1.33 
(m, 2H), 1.33–1.20 (m, 2H), 1.19–1.06 (m, 3H), 0.96 (t, J = 7.8 Hz, 3H), 0.81 (t, J = 6.6 Hz, 6H); 
13C NMR (101 MHz, CDCl3) δ 143.0, 135.85, 135.76, 135.7, 135.6, 129.24, 129.22, 128.7, 128.4, 
127.90, 127.89, 125.8, 39.1, 36.1, 32.5, 28.6, 27.7, 23.0, 22.9, 22.7, 8.0, 4.5; 
FT‐IR (thin film) 3068, 3025, 2953, 2925, 2872, 1496, 1458, 1427, 1108, 1010 cm‐1; 
HR‐MS (ESI+) m/z [M+H]+–H2 calcd for C28H35Si: 399.2508, found: 399.2499; 
[α]23D = +10.6 (c = 0.60, CHCl3); +91% ee from (S,S)–L*. 
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IV.  Mechanistic Experiments 
 
(1-Bromo-3-phenylpropyl)(ethyl)diphenylsilane was separated via preparative-scale SFC 
on a CHIRALPAK AD-H column (2% i-PrOH, 4.0 mL/min) with tr = 3.9 min, 5.0 min.  
Procedure. In a glovebox, an oven-dried 4-mL vial was charged with rac-, (+)-, or (–)-(1-
bromo-3-phenylpropyl)(ethyl)diphenylsilane (29 mg, 0.070 mmol), followed by NiBr2diglyme 
(2.5 mg, 0.0070 mmol) and then L* (3.0 mg, 0.0091 mmol). Next, an oven-dried stir bar was 
added, followed by anhydrous DMA (0.3 mL). The reaction mixture was stirred for 10 min, 
and then (2-(1,3-dioxolan-2-yl)ethyl)zinc bromide (0.084 mmol) was added, and the vial was 
capped and removed from the glovebox. The vial cap was wrapped with electrical tape, and 
the mixture was allowed to stir at room temperature for 30 min. After 30 min, EtOH (0.20 mL) 
was added, and the mixture was allowed to stir for 10 min. Next, tetradecane (internal 
standard for GC analysis; 20 μL), hexanes (0.50 mL), and Et2O (2.0 mL) were added. The 
mixture was then passed through a short plug of silica gel into a test tube, flushing with Et2O. 
An aliquot of the filtrate was removed for GC analysis. The remaining filtrate was the 
concentrated, and H2O (~2 mL) and 1:1 hexanes/Et2O (~1 mL) were added. The test tube was 
capped and thoroughly shaken. The organic layer was extracted and placed on a preparative 
TLC plate to separate the remaining electrophile from the product (eluent 50:1 hexanes/Et2O; 
electrophile: Rf ~ 0.6; product: Rf ~ 0.2). 
SFC analysis of remaining electrophile: The ee was determined via SFC on a CHIRALCEL 
OJ column (3% i-PrOH in supercritical CO2, 3.5 mL/min) with tr = 4.6 min, 5.6 min. 
SFC analysis of product: The ee was determined via SFC on a CHIRALCEL OJ column 35% 
i-PrOH in supercritical CO2, 3.5 mL/min) with tr = 6.8 min (major (S,S)–L*), 4.4 min (minor 
(S,S)–L*). 
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V.  Determination of Absolute Stereochemistry 
 
 
Table 3, entry 2: The absolute configuration of (R)-ethyl(6-phenoxy-1-phenylhexan-3-
yl)diphenylsilane ((R,R)–L*) was determined after an enantiospecific Fleming-Tamao 
oxidation13 to yield (R)-6-phenoxy-1-phenylhexan-3-ol. The absolute configuration of this 
molecule has previously been determined by single crystal x-ray diffraction.14 Comparison of 
HPLC data established the absolute configuration illustrated above. 
HPLC analysis: The ee was determined via HPLC on a CHIRALPAK AS-H column (3% i-
PrOH in hexanes, 1.0 mL/min) with tr = 19.5 min (major (S,S)–L*), 14.4 min (major (R,R)–L*). 
 
 
 
 
Table 2, entry 2: Single crystals of (S)-(4-(1,3-dioxolan-2-yl)-1-phenylbutan-2-
yl)(ethyl)diphenylsilane ((S,S)–L*) were obtained after slow evaporation from Et2O. The crystal 
                                                 
(13) Suginome, M.; Iwanami, T.; Ohmori, Y.; Matsumoto, A.; Ito, Y. Chem. Eur. J. 2005, 11, 
2954−2965. 
(14) Schmidt, J.; Choi, J.; Liu, A. T.; Slusarczyk, M.; Fu, G. C. Science 2016, 354, 1265–1269. 
PhEtPh2Si HO Ph
OPh OPh
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was kept at 99.95 K during data collection. Using Olex2,15 the structure was solved with the 
XT16 structure solution program using intrinsic phasing and refined with the ShelXL17 
refinement package using least squares minimization. 
 
  
 
Table S1. Crystal data and structure refinement for (S)-(4-(1,3-dioxolan-2-yl)-1-phenylbutan-2-
yl)(ethyl)diphenylsilane. 
 
Identification code 
(S)-(4-(1,3-dioxolan-2-yl)-1-phenylbutan-2-
yl)(ethyl)diphenylsilane  
Empirical formula C27H32O2Si 
Formula weight 416.61 
Temperature/K 99.95 
Crystal system orthorhombic 
Space group P212121 
a/Å 10.5454(9) 
b/Å 12.0533(11) 
c/Å 18.5574(17) 
α/° 90 
β/° 90 
γ/° 90 
Volume/Å3 2358.8(4) 
Z 4 
ρcalcg/cm3 1.173 
                                                 
(15) Dolomanov, O. V.; Bourhis, L. J.; Gildea, R. J.; Howard, J. A. K.; Puschmann, H. J. Appl. 
Crystallogr. 2009, 42, 339−341. 
(16) Sheldrick, G. M. Acta Cryst. 2015, A71, 3–8. 
(17) Sheldrick, G. M. Acta Cryst. 2015, C71, 3–8. 
 S–36 
μ/mm-1 0.120 
F(000) 896.0 
Crystal size/mm3 0.27 × 0.23 × 0.18 
Radiation MoKα (λ = 0.71073) 
2Θ range for data collection/° 4.442 to 55.002 
Index ranges -13 ≤ h ≤ 13, -15 ≤ k ≤ 15, -24 ≤ l ≤ 24 
Reflections collected 111480 
Independent reflections 5412 [Rint = 0.0467, Rsigma = 0.0137] 
Data/restraints/parameters 5412/0/272 
Goodness-of-fit on F2 1.038 
Final R indexes [I>=2σ (I)] R1 = 0.0316, wR2 = 0.0845 
Final R indexes [all data] R1 = 0.0330, wR2 = 0.0852 
Largest diff. peak/hole / e Å-3 0.46/-0.28 
Flack parameter 0.018(12) 
 
 
Table S2. Fractional atomic coordinates (×104) and equivalent isotropic displacement 
parameters (Å2×103) for (S)-(4-(1,3-dioxolan-2-yl)-1-phenylbutan-2-yl)(ethyl)diphenylsilane. 
Ueq is defined as 1/3 of the trace of the orthogonalised UIJ tensor. 
 
Atom x y z U(eq) 
Si01 6941.8(4) 874.1(4) 6709.4(3) 17.18(12) 
O002 2430.2(12) 2989.1(13) 5609.7(8) 23.9(3) 
O003 2811.4(12) 2372.1(14) 6747.5(8) 28.2(3) 
C004 8442.3(18) 175.9(15) 6410.0(11) 18.3(4) 
C005 10176.5(19) -53.2(18) 5557.1(11) 22.9(4) 
C006 9083.7(18) 495.2(16) 5785.6(11) 20.1(4) 
C007 6863.4(16) 2354.5(14) 6376.8(9) 16.0(3) 
C008 3278.3(16) 3093.8(17) 6196.7(10) 19.1(4) 
C009 8028.1(16) 4213.3(15) 6387(1) 18.7(3) 
C00A 8238.1(18) 4379.8(17) 5651.3(11) 23.0(4) 
C00B 7956.2(17) 3052.1(14) 6694.5(10) 18.2(3) 
C00C 5568.1(16) 2884.7(16) 6565.2(10) 17.1(4) 
C00D 4590.6(17) 2750.8(18) 5967.3(11) 21.4(4) 
C00E 1220.8(18) 2897(2) 5947.1(12) 26.1(4) 
C00F 8931.4(19) -729.8(17) 6793.5(12) 25.0(4) 
C00G 8064(2) 985.1(16) 8121.2(11) 25.2(4) 
C00H 8295.2(19) 5445.9(19) 5367.0(12) 28.1(4) 
 S–37 
C00I 10635.8(18) -945.3(18) 5946.2(11) 24.6(4) 
C00J 6937.4(18) 920.2(15) 7722.4(10) 20.9(4) 
C00K 5793(2) 970.4(18) 8106.0(11) 26.2(4) 
C00L 10010(2) -1293.9(18) 6561.9(12) 27.3(5) 
C00M 7903(2) 6208.7(17) 6538.7(12) 30.5(5) 
C00N 1496.9(19) 2189(2) 6607.0(12) 28.6(5) 
C00O 7863.2(19) 5140.6(16) 6824.8(11) 23.9(4) 
C00P 8129(2) 6360.0(18) 5809.3(13) 31.2(5) 
C00Q 8053(3) 1094.3(18) 8867.7(12) 32.3(5) 
C00R 5546(2) 62.5(18) 6356.3(13) 27.8(5) 
C00S 6905(3) 1139.6(18) 9231.5(12) 35.3(5) 
C00T 5775(2) 1080.0(19) 8852.8(13) 32.9(5) 
C00U 5590(3) -1169(2) 6518.8(16) 41.1(6) 
 
 
Table S3. Anisotropic displacement parameters (Å2×103) for (S)-(4-(1,3-dioxolan-2-yl)-1-
phenylbutan-2-yl)(ethyl)diphenylsilane.. The anisotropic displacement factor exponent takes 
the form: -2π2[h2a*2U11+2hka*b*U12+…]. 
 
Atom U11 U22 U33 U23 U13 U12 
Si01 13.3(2) 14.1(2) 24.1(2) -1.95(19) 2.36(19) -0.82(19) 
O002 13.1(6) 36.1(8) 22.6(7) 2.7(6) -3.7(5) 0.9(6) 
O003 14.4(6) 43.8(9) 26.4(7) 10.4(7) -2.6(5) -5.2(6) 
C004 16.3(8) 14.3(8) 24.2(9) -4.3(7) 0.0(7) -1.1(6) 
C005 20.1(9) 25.8(10) 22.7(10) -4.9(8) 3.2(7) 0.4(8) 
C006 18.9(8) 17.5(9) 23.9(10) -2.1(7) -1.7(7) 0.9(7) 
C007 11.7(7) 16.9(8) 19.6(8) -1.6(7) -0.1(7) 0.9(6) 
C008 13.8(8) 23.4(9) 20.2(9) 0.8(7) -1.3(7) 1.0(7) 
C009 12.2(7) 18.4(8) 25.6(9) 2.2(7) -4.0(7) -1.2(7) 
C00A 18.5(8) 24.8(10) 25.6(9) -0.8(8) 0.0(7) 0.9(7) 
C00B 13.7(7) 16.7(8) 24.2(9) 1.6(7) -3.1(8) 0.3(6) 
C00C 12.7(7) 19.1(9) 19.4(9) -1.6(7) -0.8(6) 2.5(7) 
C00D 15.0(8) 30.1(11) 19.1(9) -1.3(8) -0.9(7) 4.8(7) 
C00E 12.6(8) 31.7(11) 34.0(11) -3.2(9) -2.7(8) -0.6(8) 
C00F 24.8(9) 21.3(10) 28.9(10) 1.4(9) 5.2(8) 3.3(8) 
C00G 28.7(9) 18.1(9) 28.9(10) 1.5(8) 3.2(8) -5.3(8) 
C00H 21.9(10) 33.1(11) 29.4(10) 9.1(9) -1.6(8) -2.2(8) 
C00I 18.8(8) 24.4(10) 30.7(10) -7.9(9) 0.3(7) 3.3(8) 
 S–38 
C00J 24.7(8) 12.6(7) 25.5(9) 1.1(7) 4.3(8) -0.5(8) 
C00K 28.4(10) 20.1(10) 30.1(11) 6.0(8) 8.0(8) 4.3(8) 
C00L 24.8(10) 21.2(10) 35.8(12) 0.5(9) -1.2(8) 7.4(8) 
C00M 35.4(11) 18.6(9) 37.6(12) -1.6(8) -5.6(10) -0.1(8) 
C00N 18.4(9) 41.5(12) 25.9(11) -1.8(9) -2.3(8) -10.1(8) 
C00O 24.8(9) 20.8(9) 26.2(10) -0.5(8) -3.5(8) -1.5(8) 
C00P 29.7(10) 22.0(9) 41.8(12) 10.6(9) -6.4(10) -3.8(9) 
C00Q 43.7(12) 23.9(11) 29.1(10) 1.3(8) -4(1) -10.1(10) 
C00R 22.7(10) 24.3(11) 36.5(12) -6.1(9) -0.2(9) -6.2(8) 
C00S 58.5(15) 22.5(10) 24.9(10) -0.1(8) 9.1(11) -3.5(10) 
C00T 44.7(13) 23.6(12) 30.4(11) 5.5(9) 15.4(10) 5.6(9) 
C00U 42.9(14) 25.3(12) 55.1(16) 1.7(11) -5.9(12) -10.6(10) 
 
 
Table S4. Bond lengths for (S)-(4-(1,3-dioxolan-2-yl)-1-phenylbutan-2-yl)(ethyl)diphenylsilane. 
 
Atom Atom Length/Å  Atom Atom Length/Å 
Si01 C004 1.8763(19)  C009 C00O 1.393(3) 
Si01 C007 1.8899(18)  C00A C00H 1.390(3) 
Si01 C00J 1.8806(19)  C00C C00D 1.523(3) 
Si01 C00R 1.885(2)  C00E C00N 1.521(3) 
O002 C008 1.415(2)  C00F C00L 1.393(3) 
O002 C00E 1.425(2)  C00G C00J 1.402(3) 
O003 C008 1.430(2)  C00G C00Q 1.392(3) 
O003 C00N 1.428(2)  C00H C00P 1.385(3) 
C004 C006 1.396(3)  C00I C00L 1.385(3) 
C004 C00F 1.402(3)  C00J C00K 1.403(3) 
C005 C006 1.395(3)  C00K C00T 1.392(3) 
C005 C00I 1.383(3)  C00M C00O 1.393(3) 
C007 C00B 1.544(2)  C00M C00P 1.386(3) 
C007 C00C 1.548(2)  C00Q C00S 1.388(4) 
C008 C00D 1.506(2)  C00R C00U 1.515(3) 
C009 C00A 1.397(3)  C00S C00T 1.385(4) 
C009 C00B 1.513(2)     
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Table S5. Bond angles for (S)-(4-(1,3-dioxolan-2-yl)-1-phenylbutan-2-yl)(ethyl)diphenylsilane. 
 
Atom Atom Atom Angle/˚  Atom Atom Atom Angle/˚ 
C004 Si01 C007 111.32(8)  C00H C00A C009 120.68(19) 
C004 Si01 C00J 108.14(9)  C009 C00B C007 113.40(14) 
C004 Si01 C00R 108.83(9)  C00D C00C C007 112.89(15) 
C00J Si01 C007 107.36(8)  C008 C00D C00C 112.76(16) 
C00J Si01 C00R 111.16(10)  O002 C00E C00N 103.08(15) 
C00R Si01 C007 110.02(9)  C00L C00F C004 121.60(19) 
C008 O002 C00E 103.55(14)  C00Q C00G C00J 121.6(2) 
C00N O003 C008 107.34(15)  C00P C00H C00A 120.3(2) 
C006 C004 Si01 122.06(15)  C005 C00I C00L 120.00(18) 
C006 C004 C00F 117.25(18)  C00G C00J Si01 121.81(15) 
C00F C004 Si01 120.62(15)  C00G C00J C00K 117.33(17) 
C00I C005 C006 119.95(19)  C00K C00J Si01 120.71(15) 
C005 C006 C004 121.48(19)  C00T C00K C00J 121.4(2) 
C00B C007 Si01 110.91(12)  C00I C00L C00F 119.7(2) 
C00B C007 C00C 110.34(14)  C00P C00M C00O 119.9(2) 
C00C C007 Si01 110.77(12)  O003 C00N C00E 104.25(16) 
O002 C008 O003 106.16(15)  C009 C00O C00M 121.02(19) 
O002 C008 C00D 109.80(15)  C00H C00P C00M 119.72(19) 
O003 C008 C00D 110.59(16)  C00S C00Q C00G 119.7(2) 
C00A C009 C00B 120.60(17)  C00U C00R Si01 114.53(17) 
C00O C009 C00A 118.33(18)  C00T C00S C00Q 120.1(2) 
C00O C009 C00B 121.06(17)  C00S C00T C00K 119.9(2) 
 
 
Table S6. Torsion angles for (S)-(4-(1,3-dioxolan-2-yl)-1-phenylbutan-2-
yl)(ethyl)diphenylsilane. 
 
A B C D Angle/˚  A B C D Angle/˚ 
Si01 C004 C006 C005 -177.98(15)  C00B C009 C00O C00M -178.64(19) 
Si01 C004 C00F C00L 176.90(17)  C00C C007 C00B C009 -63.0(2) 
Si01 C007 C00B C009 173.86(12)  C00E O002 C008 O003 38.07(19) 
Si01 C007 C00C C00D -91.97(17)  C00E O002 C008 C00D 157.63(17) 
Si01 C00J C00K C00T -175.63(17)  C00F C004 C006 C005 -0.9(3) 
O002 C008 C00D C00C 177.77(16)  C00G C00J C00K C00T 0.0(3) 
O002 C00E C00N O003 24.9(2)  C00G C00Q C00S C00T -0.2(3) 
 S–40 
O003 C008 C00D C00C -65.4(2)  C00I C005 C006 C004 1.0(3) 
C004 Si01 C007 C00B -62.49(14)  C00J Si01 C004 C006 -144.74(16) 
C004 Si01 C007 C00C 174.63(12)  C00J Si01 C004 C00F 38.25(18) 
C004 Si01 C00J C00G 30.26(18)  C00J Si01 C007 C00B 55.69(14) 
C004 Si01 C00J C00K -154.32(16)  C00J Si01 C007 C00C -67.19(14) 
C004 Si01 C00R C00U 51.1(2)  C00J Si01 C00R C00U -67.9(2) 
C004 C00F C00L C00I 1.3(3)  C00J C00G C00Q C00S 0.1(3) 
C005 C00I C00L C00F -1.2(3)  C00J C00K C00T C00S -0.1(3) 
C006 C004 C00F C00L -0.2(3)  C00N O003 C008 O002 -21.9(2) 
C006 C005 C00I C00L 0.1(3)  C00N O003 C008 C00D -140.90(17) 
C007 Si01 C004 C006 -27.02(18)  C00O C009 C00A C00H 0.7(3) 
C007 Si01 C004 C00F 155.97(16)  C00O C009 C00B C007 117.41(19) 
C007 Si01 C00J C00G -89.97(17)  C00O C00M C00P C00H 1.0(3) 
C007 Si01 C00J C00K 85.45(17)  C00P C00M C00O C009 -1.0(3) 
C007 Si01 C00R C00U 173.35(18)  C00Q C00G C00J Si01 175.60(16) 
C007 C00C C00D C008 170.42(16)  C00Q C00G C00J C00K 0.0(3) 
C008 O002 C00E C00N -38.2(2)  C00Q C00S C00T C00K 0.2(3) 
C008 O003 C00N C00E -2.1(2)  C00R Si01 C004 C006 94.40(18) 
C009 C00A C00H C00P -0.8(3)  C00R Si01 C004 C00F -82.61(18) 
C00A C009 C00B C007 -61.3(2)  C00R Si01 C007 C00B 176.78(13) 
C00A C009 C00O C00M 0.1(3)  C00R Si01 C007 C00C 53.90(15) 
C00A C00H C00P C00M -0.1(3)  C00R Si01 C00J C00G 149.66(16) 
C00B C007 C00C C00D 144.82(16)  C00R Si01 C00J C00K -34.92(19) 
C00B C009 C00A C00H 179.53(17)       
 
 
Table S7. Hydrogen atom coordinates (Å×104) and isotropic displacement parameters (Å2×103) 
for (S)-(4-(1,3-dioxolan-2-yl)-1-phenylbutan-2-yl)(ethyl)diphenylsilane. 
 
Atom x y z U(eq) 
H005 10605 186 5134 27 
H006 8769 1100 5510 24 
H007 6955 2348 5840 19 
H008 3288 3877 6374 23 
H00A 8343 3758 5342 28 
H00B 7846 3102 7223 22 
H00C 8769 2667 6601 22 
H00D 5237 2539 7011 20 
 S–41 
H00E 5693 3685 6662 20 
H00F 4851 3204 5548 26 
H00G 4572 1965 5813 26 
H00H 601 2529 5625 31 
H00I 889 3635 6087 31 
H00J 8517 -965 7222 30 
H00K 8854 954 7876 30 
H00L 8449 5548 4867 34 
H00M 11381 -1319 5791 30 
H00N 5013 929 7851 31 
H00O 10315 -1915 6825 33 
H00P 7775 6833 6843 37 
H00Q 972 2426 7022 34 
H00R 1329 1396 6507 34 
H00S 7721 5043 7326 29 
H00T 8171 7087 5614 37 
H00U 8828 1138 9127 39 
H00V 4761 375 6566 33 
H00W 5500 164 5828 33 
H00X 6893 1212 9741 42 
H00Y 4989 1114 9102 39 
H00Z 6305 -1506 6262 62 
H 4797 -1517 6361 62 
HA 5698 -1280 7038 62 
 
  
VI. 1H and 13C NMR Data; ee Analysis 
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